Serum 25-hydroxyvitamin D levels: Variability, knowledge gaps, and the concept of a desirable range

Journal article


El-Hajj Fuleihan, Ghada, Bouillon, Roger, Clarke, Bart, Chakhtoura, Marlene, Cooper, Cyrus, McClung, Michael R. and Singh, Ravinder J.. (2015). Serum 25-hydroxyvitamin D levels: Variability, knowledge gaps, and the concept of a desirable range. Journal of Bone and Mineral Research. 30(7), pp. 1119 - 1133. https://doi.org/10.1002/jbmr.2536
AuthorsEl-Hajj Fuleihan, Ghada, Bouillon, Roger, Clarke, Bart, Chakhtoura, Marlene, Cooper, Cyrus, McClung, Michael R. and Singh, Ravinder J.
Abstract

Hypovitaminosis D is prevalent worldwide but proportions vary widely between regions, depending on genetic and lifestyle factors, the threshold to define deficiency, and accuracy of 25-hydroxyvitamin D (25OHD) assays used. Latitude, pollution, concealing clothing, sun exposure, gender, dietary habits, and lack of government regulation account for up to 50% in variations in serum 25OHD levels, whereas genetic polymorphisms in the vitamin D pathway account for less than 5%. Organizations/societies have developed guidelines for recommended desirable 25OHD levels and vitamin D doses to reach them, but their applicability across age groups and populations are still debated. This article and the accompanying online Supporting Information highlight sources of variations in circulating 25OHD levels, uncertainties and knowledge gaps, and analytical problems facing 25OHD assays, while keeping efficacy and safety data as the dominant factors when defining a desirable range for 25OHD levels. We propose a desirable range of 20 to 40 ng/mL (50 to 100 nmol/L), provided precise and accurate assays are used. Although slightly lower levels, 15 to 20 ng/mL, may be sufficient for some infants and adults, higher levels, 40 to 60 ng/mL, may still be safe. This desirable range allows physicians to tailor treatment while taking season, lifestyle, vitamin D intake, and other sources of variation into account. We reserve 25OHD measurements for at-risk patients, defined by disease or lifestyle, and the use of 25OHD assays calibrated against the recommended international standards. Most target groups reach desirable target levels by a daily intake of 400 to 600 IU for children and 800 IU for adults. A total daily allowance of vitamin D of up to 1000 IU in the pediatric age groups, and up to 2000 IU in adults, tailored to an individual patient risk profile, is probably safe over long durations. Additional data are needed to validate the proposed range and vitamin D doses, especially in children, pregnant women, and non-white populations.

Keywordsdesirable range; vitamin D; knowledge gaps; variations; ethnicities; safety; efficacy
Year2015
JournalJournal of Bone and Mineral Research
Journal citation30 (7), pp. 1119 - 1133
PublisherJohn Wiley & Sons, Inc.
ISSN0884-0431
Digital Object Identifier (DOI)https://doi.org/10.1002/jbmr.2536
Page range1119 - 1133
Research GroupInstitute for Health and Ageing
Publisher's version
File Access Level
Controlled
Place of publicationUnited States of America
Permalink -

https://acuresearchbank.acu.edu.au/item/858xx/serum-25-hydroxyvitamin-d-levels-variability-knowledge-gaps-and-the-concept-of-a-desirable-range

Restricted files

Publisher's version

  • 113
    total views
  • 0
    total downloads
  • 4
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms
McClung, Michael R., Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian and Constantine, Ginger. (2022). Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms. Menopause. 29(3), pp. 304-308. https://doi.org/10.1097/GME.0000000000001915
Should vitamin D supplements be prescribed routinely for midlife women?
McClung, Michael Roy. (2022). Should vitamin D supplements be prescribed routinely for midlife women? Menopause. 29(11), pp. 1329-1330. https://doi.org/10.1097/GME.0000000000002066
Proceedings of the 2022 Santa Fe Bone Symposium : Current concepts in the care of patients with osteoporosis and metabolic bone diseases
Lewiecki, E. Michael, Bilezikian, John P., Binkley, Neil, Bouxsein, Mary L., Bukata, Susan V., Dempster, David W., Drake, Matthew T., McClung, Michael R., Miller, Paul D., Rosenthal, Elisabeth and Tosi, Laura L.. (2022). Proceedings of the 2022 Santa Fe Bone Symposium : Current concepts in the care of patients with osteoporosis and metabolic bone diseases. Journal of Clinical Densitometry. 25(4), pp. 649-667. https://doi.org/10.1016/j.jocd.2022.10.002
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis
Hans, Didier, Shevroja, Enisa, McDermott, Michele, Huang, Shuang, Kim, Min and McClung, Michael Roy. (2022). Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis. Osteoporosis International. 33(12), pp. 2517-2525. https://doi.org/10.1007/s00198-022-06549-x
An updated hip fracture incidence rate for Brazil : the Brazilian Validation Osteoporosis Study (BRAVOS)
Albergaria, Ben-Hur, Zerbini, Cristiano, Szejnfeld, Vera, Ragi Eis, Sergio, Silva, Dalisbor, da Cunha, Maria, McClung, Michael Roy, Kanis, John Anthony, McCloskey, Eugene, Vilaca, Tatiane and Lazaretti-Castro, Marise. (2022). An updated hip fracture incidence rate for Brazil : the Brazilian Validation Osteoporosis Study (BRAVOS). Archives of Osteoporosis. 17, pp. 1-9. https://doi.org/10.1007/s11657-022-01127-4
The role of osteoanabolic agents in the management of patients with osteoporosis
McClung, Michael R., Rothman, Micol S., Lewiecki, E. Michael, Hanley, David A., Harris, Steven T., Miller, Paul D. and Kendler, David L.. (2022). The role of osteoanabolic agents in the management of patients with osteoporosis. Postgraduate Medicine. 134(6), pp. 541-551. https://doi.org/10.1080/00325481.2022.2069582
Proceedings of the 2021 Santa Fe Bone Symposium : Advances in the management of osteoporosis and metabolic bone diseases
Lewiecki, E. Michael, Anderson, Paul A., Bilezikian, John P., Binkley, Neil, Cheung, Angela M., Imel, Erik A., Krueger, Diane, McClung, Michael R., Miller, Paul D. and Rothman, Micol S.. (2022). Proceedings of the 2021 Santa Fe Bone Symposium : Advances in the management of osteoporosis and metabolic bone diseases. Journal of Clinical Densitometry. 25(1), pp. 3-19. https://doi.org/10.1016/j.jocd.2021.10.001
Denosumab for the treatment of osteoporosis
McClung, Michael R.. (2021). Denosumab for the treatment of osteoporosis. In In Dempster, David W., Cauley, Jane A., Bouxsein, Mary L. and Cosman, Felicia (Ed.). Marcus and Feldman’s osteoporosis pp. 1737-1755 Academic Press. https://doi.org/10.1016/B978-0-12-813073-5.00075-7
Osteoanabolic therapy for osteoporosis in women
McClung, M. R. and Clark, A. L.. (2021). Osteoanabolic therapy for osteoporosis in women. Climacteric. 25(1), pp. 60-66. https://doi.org/10.1080/13697137.2021.1953463
Short time horizons for fracture prediction tools : Time for a rethink
McCloskey, E. V., Borgstrom, F., Cooper, C., Harvey, N. C., Javaid, M. K., Lorentzon, M. and Kanis, J. A.. (2021). Short time horizons for fracture prediction tools : Time for a rethink. Osteoporosis International. 32(6), pp. 1019-1025. https://doi.org/10.1007/s00198-021-05962-y
Skeletal responses to romosozumab after 12 months of denosumab
McClung, Michael R., Bolognese, Michael A., Brown, Jacques P., Reginster, Jean-Yves, Langdahl, Bente L., Shi, Yifei, Timoshanko, Jen, Libanati, Cesar, Chines, Arkadi and Oates, Mary K.. (2021). Skeletal responses to romosozumab after 12 months of denosumab. JBMR Plus. 5(7), p. Article e10512. https://doi.org/10.1002/jbm4.10512
Sarcopenia definitions as predictors of fracture risk independent of FRAX®, falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study : A meta-analysis
Harvey, Nicholas C., Orwoll, Eric, Kwok, Timothy, Karlsson, Magnus K., Rosengren, Björn E., Ribom, Eva, Cauley, Jane A., Cawthon, Peggy M., Ensrud, Kristine, Liu, Enwu, Cruz-Jentoft, Alfonso J., Fielding, Roger A., Cooper, Cyrus, Kanis, John A., Lorentzon, Mattias, Ohlsson, Claes, Mellström, Dan, Johansson, Helena and McCloskey, Eugene. (2021). Sarcopenia definitions as predictors of fracture risk independent of FRAX®, falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study : A meta-analysis. Journal of Bone and Mineral Research. 36(7), pp. 1235-1244. https://doi.org/10.1002/jbmr.4293
Incidence of hip and subtrochanteric/femoral shaft fractures in postmenopausal women with osteoporosis in the phase 3 long-term odanacatib fracture trial
Papapoulos, Socrates, Bone, Henry, Cosman, Felicia, Dempster, David W., McClung, Michael R., Nakamura, Toshitaka, Restrepo, José Fernando Molina, Bouxsein, Mary L., Cohn, Dosinda, de Papp, Anne, Massaad, Rachid and Santora, Arthur. (2021). Incidence of hip and subtrochanteric/femoral shaft fractures in postmenopausal women with osteoporosis in the phase 3 long-term odanacatib fracture trial. Journal of Bone and Mineral Research. 36(7), pp. 1225-1234. https://doi.org/10.1002/jbmr.4284
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan
Hagino, H., Tanaka, K., Silverman, S., McClung, M., Gandra, S. R., Charokopou, M., Adachi, K., Johnson, B. and Stollenwerk, B.. (2021). Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan. Osteoporosis International. 32, pp. 2011-2021. https://doi.org/10.1007/s00198-021-05927-1
A multicenter study to evaluate harmonization of assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX) : A report from the IFCC-IOF Committee for Bone Metabolism (C-BM)
Cavalier, E., Eastell, R., Jørgensen, N. R., Makris, K., Tournis, S., Vasikaran, S., Kanis, J. A., Cooper, C., Pottel, H. and Morris, H. A.. (2021). A multicenter study to evaluate harmonization of assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX) : A report from the IFCC-IOF Committee for Bone Metabolism (C-BM). Calcified Tissue International. 108(6), pp. 785-797. https://doi.org/10.1007/s00223-021-00816-5
Role of bone-forming agents in the management of osteoporosis
McClung, Michael R.. (2021). Role of bone-forming agents in the management of osteoporosis. Aging Clinical and Experimental Research. 33, pp. 775-791. https://doi.org/10.1007/s40520-020-01708-8
Predictive value of DXA appendicular lean mass for incident fractures, falls, and mortality, independent of prior falls, FRAX, and BMD : Findings from the Women's Health Initiative (WHI)
Harvey, Nicholas C., Kanis, John A., Liu, Enwu, Cooper, Cyrus, Lorentzon, Mattias, Bea, Jennifer W., Carbone, Laura, Cespedes Feliciano, Elizabeth M., Laddu, Deepika R., Schnatz, Peter F., Shadyab, Aladdin H., Stefanick, Marcia L., Wactawski-Wende, Jean, Crandall, Carolyn J., Johansson, Helena and McCloskey, Eugene. (2021). Predictive value of DXA appendicular lean mass for incident fractures, falls, and mortality, independent of prior falls, FRAX, and BMD : Findings from the Women's Health Initiative (WHI). Journal of Bone and Mineral Research. 36(4), pp. 654-661. https://doi.org/10.1002/jbmr.4239
Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood
Bhattoa, Harjit P., Cavalier, Etienne, Eastell, Richard, Heijboer, Annemieke C., Jørgensen, Niklas R., Makris, Konstantinos, Ulmer, Candice Z., Kanis, John A., Cooper, Cyrus, Silverman, Stuart L. and Vasikaran, Samuel D.. (2021). Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood. Clinica Chimica Acta. 515, pp. 16-20. https://doi.org/10.1016/j.cca.2020.12.023
The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society
Faubion, Stephanie S., Kingsberg, Sheryl A., Clark, Amanda L., Kaunitz, Andrew M., Spadt, Susan Kellogg, Larkin, Lisa C., Mitchell, Caroline M., Shifren, Jan L., Simon, James A. and McClung, Michael R.. (2020). The 2020 genitourinary syndrome of menopause position statement of the North American Menopause Society. Menopause. 27(9), pp. 976-992. https://doi.org/10.1097/GME.0000000000001609
Machine learning to predict osteoporotic fracture risk from genotypes
Forgetta, Vincenzo, Keller-Baruch, Julyan, Forest, Marie, Durand, Audrey, Bhatnagar, Sahir, Kemp, John, Morris, John A., Kanis, John A., Kiel, Douglas P., McCloskey, Eugene V., Rivadeneira, Fernando, Johannson, Helena, Harvey, Nicholas, Cooper, Cyrus, Evans, David M., Pineau, Joelle, Leslie, William D., Greenwood, Celia M. T. and Richards, J. Brent. (2020). Machine learning to predict osteoporotic fracture risk from genotypes. Cold Spring Harbor Protocols. pp. 1-22. https://doi.org/10.1101/413716
Screening for high hip fracture risk does not impact on falls risk : A post hoc analysis from the SCOOP study
Condurache, C. I., Chiu, S., Chotiyarnwong, P., Johansson, H., Shepstone, L., Lenaghan, E., Cooper, C., Clarke, S., Khioe, R. F. S., Fordham, R., Gittoes, N., Harvey, I., Harvey, N. C., Heawood, A., Holland, R., Howe, A., Kanis, J. A., Marshall, T., O’Neill, T. W., ... the SCOOP Study Team. (2020). Screening for high hip fracture risk does not impact on falls risk : A post hoc analysis from the SCOOP study. Osteoporosis International. 31(3), pp. 457-464. https://doi.org/10.1007/s00198-019-05270-6
Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women : Systemic review and meta-analysis
Wu, Chih-Hsing, Hung, Wei-Chieh, Chang, Ing-Lin, Tsai, Tsung-Ting, Chang, Yin-Fan, McCloskey, Eugene V., Watts, Nelson B., McClung, Michael R., Huang, Chun-Feng, Chen, Chung-Hwan, Wu, Kun-Ling, Tsai, Keh-Sung, Chan, Ding-Cheng, Chen, Jung-Fu, Tu, Shih-Te, Hwang, Jawl-Shan, Xia, Weibo, Matsumoto, Toshio, Chung, Yoon-Sok, ... Chan, Wing P.. (2020). Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women : Systemic review and meta-analysis. Bone Reports. 13, p. 100729. https://doi.org/10.1016/j.bonr.2020.100729
Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend
S L Greenspan, Lorraine A. Fitzpatrick, Bruce Mitlak, Yamei Wang, Nicholas C. Harvey, Chad Deal, F. Cosman and Michael McClung. (2020). Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend. Menopause: The Journal of the North American Menopause Society. 27(10), pp. 1137-1142. https://doi.org/10.1097/GME.0000000000001593
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
McClung, Michael, Bolognese, Michael A, Brown, Jacques P, Reginster, Jean Yves, Langdahl, Bente Lomholt, Maddox, Judy, Shi, Y., Rojeski, M., Meisner, Paul and Grauer, Andreas. (2020). A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab. Osteoporosis International. 31, pp. 2231-2241. https://doi.org/10.1007/s00198-020-05502-0
FRAX and ethnicity
Kanis, J. A., Cooper, C., Dawson-Hughes, B., Harvey, N. C., Johansson, H., Lorentzon, M., McCloskey, E. V., Reginster, J. Y., Rizzoli, R. and International Osteoporosis Foundation. (2020). FRAX and ethnicity. Osteoporosis International. 31(11), pp. 2063-2067. https://doi.org/10.1007/s00198-020-05631-6
Assessment of cardiovascular safety of anti-osteoporosis drugs
Fuggle, N. R., Cooper, C., Harvey, N. C., Al-Daghri, N., Brandi, M. L., Bruyere, O., Cano, A., Dennison, E. M., Diez-Perez, A., Kaufman, J. M., Palacios, S., Prieto-Alhambra, D., Rozenberg, S., Thomas, T., Tremollieres, F., Rizzoli, R., Kanis, J. A. and Reginster, J. Y.. (2020). Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs: Education, Prevention and Policy. 80(15), pp. 1537-1552. https://doi.org/10.1007/s40265-020-01364-2
American Association of Clinical Endocrinologists/American College Of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 update executive summary
Camacho, Pauline M., Petak, Steven M., Binkley, Neil, Diab, Dima L., Eldeiry, Leslie S., Farooki, Azeez, Harris, Steven T., Hurley, Daniel L., Kelly, Jennifer, Lewiecki, E. Michael, Pessah-Pollack, Rachel, McClung, Michael, Wimalawansa, Sunil J. and Watts, Nelson B.. (2020). American Association of Clinical Endocrinologists/American College Of Endocrinology Clinical Practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 update executive summary. Endocrine Practice. 26(5), pp. 564-570. https://doi.org/10.4158/GL-2020-0524
Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial
Parsons, C. M., Harvey, N., Shepstone, L., Kanis, J. A., Lenaghan, E., Clarke, S., Fordham, R., Gittoes, N., Harvey, I., Holland, R., Redmond, N. M., Howe, A., Marshall, T., Peters, T. J., Torgerson, D., O’Neill, T. W., McCloskey, E., Cooper, C., Crabtree, N., ... the Scoop Trial Group. (2020). Systematic screening using FRAX® leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial. Osteoporosis International. 31(1), pp. 67-75. https://doi.org/10.1007/s00198-019-05142-z
Secondary fracture prevention : Consensus clinical recommendations from a multistakeholder coalition
Conley, Robert B., Adib, Gemma, Adler, Robert A., Åkesson, Kristina E., Alexander, Ivy M., Amenta, Kelly C., Blank, Robert D., Brox, William Timothy, Carmody, Emily E., Chapman-Novakofski, Karen, Clarke, Bart L., Cody, Kathleen M., Cooper, Cyrus, Crandall, Carolyn J., Dirschl, Douglas R., Eagen, Thomas J., Elderkin, Ann L., Fujita, Masaki, Greenspan, Susan L., ... Kiel, Douglas P.. (2020). Secondary fracture prevention : Consensus clinical recommendations from a multistakeholder coalition. Journal of Bone and Mineral Research. 35(1), pp. 36-52. https://doi.org/10.1002/jbmr.3877
Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases
E Michael Lewiecki, John P Bilezikiam, Risa Kagan, Deborah Krakow, Michael McClung, Paul Miller, Eric T Rush, Christopher R Shuhart, Nelson B Watts and Elaine W Yu. (2020). Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases. Journal of Clinical Densitometry. 23(1), pp. 1-20. https://doi.org/10.1016/j.jocd.2019.09.006
Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting : The SCOOP Study
Söreskog, E., Borgström, F., Shepstone, L., Clarke, S., Cooper, C., Harvey, I., Harvey, N. C., Howe, A., Johansson, H., Marshall, T., O’Neill, T. W., Peters, T. J., Redmond, N. M., Turner, D., Holland, R., McCloskey, E., Kanis, J. A., Heawood, A., Crabtree, N., ... SCOOP Study Team. (2020). Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting : The SCOOP Study. Osteoporosis International. 31, pp. 1499-1506. https://doi.org/10.1007/s00198-020-05372-6
History of risedronate
Michael McClung and Frank H. Ebetino. (2020). History of risedronate. Bone. 137, pp. 1-11. https://doi.org/10.1016/j.bone.2020.115407
American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 Update
Pauline Camacho, Steven M. Petak, Neil Binkley, Dima L. Diab, Leslie S. Eldeiry, Azeez Farooki, Steven T. Harris, Daniel L. Hurley, Jennifer Kelly, E Michael Lewiecki, Rachel Pessah-Pollack, Michael McClung, Sunil J. Wimalawansa and Nelson B Watts. (2020). American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 Update. Endocrine Practice. 26(Supplement 1), pp. 1-46. https://doi.org/10.4158/GL-2020-0524SUPPL
Fragility fractures in Europe : Burden, management and opportunities 
Borgström, Fredrik, Karlsson, Linda, Ortsäter, Gustav, Norton, Nicolas, Halbout, Philippe, Cooper, Cyrus, Lorentzon, Mattias, McCloskey, Eugene V., Harvey, Nicholas C., Javaid, Muhamamd K., Kanis, John A. and International Osteoporosis Foundation. (2020). Fragility fractures in Europe : Burden, management and opportunities . Archives of Osteoporosis. 15(59), pp. 1-21. https://doi.org/10.1007/s11657-020-0706-y
European Biological Variation Study (EuBIVAS) : Within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein - A cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism
Cavalier, E., Lukas, P., Bottani, M., Aarsand, A. K., Ceriotti, F., Coşkun, A., Díaz-Garzón, J., Fernàndez-Calle, P., Guerra, E., Locatelli, M., Sandberg, S., Carobene, A., European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation and IOF-IFCC Committee on Bone Metabolism, Cooper, C. and Kanis, J. A.. (2020). European Biological Variation Study (EuBIVAS) : Within- and between-subject biological variation estimates of β-isomerized C-terminal telopeptide of type I collagen (β-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fibroblast growth factor 23 and uncarboxylated-unphosphorylated matrix-Gla protein - A cooperation between the EFLM Working Group on Biological Variation and the International Osteoporosis Foundation-International Federation of Clinical Chemistry Committee on Bone Metabolism. Osteoporosis International. 31, pp. 1461-1470. https://doi.org/10.1007/s00198-020-05362-8
Development of a polygenic risk score to improve screening for fracture risk : A genetic risk prediction study
Forgetta, Vincenzo, Keller-Baruch, Julyan, Forest, Marie, Durand, Audrey, Bhatnagar, Sahir, Kemp, John P., Nethander, Maria, Evans, Daniel, Morris, John A., Kiel, Douglas P., Rivadeneira, Fernando, Johansson, Helena, Harvey, Nicholas C., Mellström, Dan, Karlsson, Magnus, Cooper, Cyrus, Evans, David M., Clarke, Robert, Kanis, John, A., ... Richards, J. Brent. (2020). Development of a polygenic risk score to improve screening for fracture risk : A genetic risk prediction study. PLoS Medicine. 17(7), pp. 1-19. https://doi.org/10.1371/journal.pmed.1003152
A pooled analysis of fall incidence from placebo-controlled trials of Denosumab
Chotiyarnwong, Pojchong, McCloskey, Eugene, Eastell, Richard, McClung, Michael R., Gielen, Evelien, Gostage, John, McDermott, Michele, Chines, Arkadi, Huang, Shuang and Cummings, Steven R.. (2020). A pooled analysis of fall incidence from placebo-controlled trials of Denosumab. Journal of Bone and Mineral Research. 35(6), pp. 1014-1021. https://doi.org/10.1002/jbmr.3972
Bone mineral density after transitioning from denosumab to alendronate
Kendler, David, Chines, Arkadi, Clark, Patricia, Ebeling, Peter R., McClung, Michael, Rhee, Yumie, Huang, Shuang and Stad, Robert Kees. (2020). Bone mineral density after transitioning from denosumab to alendronate. The Journal of Clinical Endocrinology and Metabolism. 105(3), pp. 1-10. https://doi.org/10.1210/clinem/dgz095
Odanacatib for the treatment of postmenopausal osteoporosis : Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
McClung, Michael R., O'Donoghue, Michelle L., Papapoulos, Socrates E., Bone, Henry, Langdahl, Bente, Saag, Kenneth G., Reid, Ian R., Kiel, Douglas P., Cavallari, Ilaria, Bonaca, Marc P., Wiviott, Stephen D., de Villiers, Tobias, Ling, Xu, Lippuner, Kurt, Nakamura, Toshitaka, Reginster, Jean-Yves, Rodriguez-Portales, Jose Adolfo, Roux, Christian, Zanchetta, José, ... Christiansen, Mark G.. (2019). Odanacatib for the treatment of postmenopausal osteoporosis : Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. The Lancet Diabetes & Endocrinology. 7(12), pp. 899-911. https://doi.org/10.1016/S2213-8587(19)30346-8
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis
E Michael Lewiecki, David L Kendler, K Shawn Davison, David A. Hanley, Steven T. Harris, Michael McClung and Paul Miller. (2019). Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis. American Journal of Medicine. 132(11), pp. 771-777. https://doi.org/10.1016/j.amjmed.2019.04.044
Odanacatib for the treatment of postmenopausal osteoporosis : Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
McClung, Michael R., O'Donoghue, Michelle L., Papapoulos, Socrates E., Bone, Henry, Langdahl, Bente, Saag, Kenneth G., Reid, Ian R., Kiel, Douglas P., Cavallari, Ilaria, Bonaca, Marc P., Wiviott, Stephen D., de Villiers, Tobias, Ling, Xu, Lippuner, Kurt, Nakamura, Toshitaka, Reginster, Jean-Yves, Rodriguez-Portales, Jose Adolfo, Roux, Christian, Zanchetta, José, ... Sabatine, Marc S.. (2019). Odanacatib for the treatment of postmenopausal osteoporosis : Results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. 7(12), pp. 899-911.
East meets West: current practices and policies in the management of musculoskeletal aging
Weibo Xia, Cyrus Cooper, Mei Li, Ling Xu, Rene Rizzoli, Mei Zhu, Hua Lin, John Beard, Yue Ding, Wei Yu, Etienne Cavalier, Zhenlin Zhang, John Kanis, Qun Cheng, Quimei Wang and Jean-Yves Reginster. (2019). East meets West: current practices and policies in the management of musculoskeletal aging. Aging Clinical and Experimental Research. 31(10), pp. 1351-1373. https://doi.org/10.1007/s40520-019-01282-8
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
Mattias Lorentzon, Jaime Branco, Maria Luisa Brandi, Olivier Bruyere, Roland D Chapurlat, Cyrus Cooper, Bernard Cortet, Aldolfo Diez-Perez, Serge L Ferrari, Andrea Ildiko Gasparik, Markus Herrmann, N. R. Jorgensen, John Kanis, Jean-Marc Kaufman, A. Laslop, Medea Locquet, Radmila Matijevic, Eugene McCloskey, Salvatore Minisola, ... Etienne Cavalier. (2019). Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. Advances in Therapy. 36(10), pp. 2811-2824. https://doi.org/10.1007/s12325-019-01063-9
Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis
E. Michael Lewiecki, John P. Bilezikian, Lora Giangregorio, Susan L. Greenspan, Sundeep Khosla, Paul Kostenuik, Kelly Krohn, Michael R. McClung, Paul D. Miller and Roberto Pacifici. (2019). Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis. Journal of Clinical Densitometry. 22(1), pp. 1-19. https://doi.org/10.1016/j.jocd.2018.09.010
Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., Cooper, C., Rizzoli, R. and Reginster, J.-Y.. (2019). Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Aging Clinical and Experimental Research. 31(1), pp. 15-17. https://doi.org/10.1007/s40520-018-1109-4
Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
M. Hiligsmann, J.-Y. Reginster, A.N.A. Tosteson, S.V. Bukata, K.G. Saag, D.T. Gold, P. Halbout, F. Jiwa, E.M. Lewiecki, D. Pinto, J.D. Adachi, N. Al-Daghri, O. Bruyère, M. Chandran, C. Cooper, N.C. Harvey, T.A. Einhorn, J.A. Kanis, D.L. Kendler, ... S. Silverman. (2019). Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation. Osteoporosis International. 30(1), pp. 45-57. https://doi.org/10.1007/s00198-018-4744-x
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Maarten de Wit, Cyrus Cooper, Peter Tugwell, Nathalie Bere, John Kirwan, Philip G. Conaghan, Charlotte Roberts, Isabelle Aujoulat, Nasser Al-Daghri, Islene Araujo de Carvalho, Mary Barker, Nicola Bedlington, Maria Luisa Brandi, Olivier Bruyère, Nansa Burlet, Philippe Halbout, Mickaël Hiligsmann, Famida Jiwa, John A. Kanis, ... Jean-Yves Reginster. (2019). Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research. 31(7), pp. 905-915. https://doi.org/10.1007/s40520-019-01193-8
Sarcopenia: revised European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M. Schneider, Cornel C. Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Mauro Zamboni, John Kanis, Writing Group For The European Working Group On Sarcopenia In Older People 2 (EWGSOP2) and The Extended Group For EWGSOP2*. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 48(1), pp. 16-31. https://doi.org/10.1093/ageing/afy169
Assessment of Muscle Function and Physical Performance in Daily Clinical Practice
Charlotte Beaudart, Yves Rolland, Alfonso J. Cruz-Jentoft, Jürgen M. Bauer, Cornel Sieber, Cyrus Cooper, Nasser Al-Daghri, Islene Araujo de Carvalho, Ivan Bautmans, Roberto Bernabei, Olivier Bruyère, Matteo Cesari, Antonio Cherubini, Bess Dawson-Hughes, John A. Kanis, Jean-Marc Kaufman, Francesco Landi, Stefania Maggi, Eugene McCloskey, ... Roger A. Fielding. (2019). Assessment of Muscle Function and Physical Performance in Daily Clinical Practice. Calcified Tissue International. 105(1), pp. 1-13. https://doi.org/10.1007/s00223-019-00545-w
Is there enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review
Bauer, Jurgen M., Cruz-Jentoft, Alfonso J., Fielding, Roger A., Kanis, John A., Reginster, Jean-Yves, Bruyere, Olivier, Cesari, Matteo, Chapurlat, Roland, Al-Daghri, Nasser, Dennison, Elaine M., Kaufman, Jean-Marc, Landi, Francesco, Laslop, Andrea, Locquet, Medea, Maggi, Stefania, McCloskey, Eugene, Perna, Simone, Rizzoli, Rene, Rolland, Yves, ... Cooper, Cyrus. (2019). Is there enough evidence for osteosarcopenic obesity as a distinct entity? A critical literature review. Calcified Tissue International. 105, pp. 109 - 124. https://doi.org/10.1007/s00223-019-00561-w
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., Cooper, C., Rizzoli, R. and Reginster, J.-Y.. (2019). Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcified Tissue International. 104(3), pp. 235-238. https://doi.org/10.1007/s00223-018-00512-x
Robust norms for neuropsychological tests of verbal episodic memory in Australian women
Goodwill, Alicia, Campbell, Stephen, Henderson, Victor W., Gorelik, Alexandra, Dennerstein, Lorraine, McClung, Michael and Szoeke, Cassandra. (2019). Robust norms for neuropsychological tests of verbal episodic memory in Australian women. Neuropsychology. 33(4), pp. 581 - 595. https://doi.org/10.1037/neu0000522
Osteoporosis
Compston, Juliet E., McClung, Michael R. and Leslie, William D.. (2019). Osteoporosis. The Lancet. 393(10169), pp. 364 - 376. https://doi.org/10.1016/S0140-6736(18)32112-3
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, John A., Cooper, Cyrus, Rizzoli, Rene and Reginster, Jean-Yves. (2019). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International. 30(1), pp. 3 - 44. https://doi.org/10.1007/s00198-018-4704-5
Bone age as a correction factor for the analysis of trabecular bone score (TBS) in children
Guagnelli, Miguel Angel, Winzenrieth, Renaud, Lopez-Gonzalez, Desiree, McClung, Michael R., Del Rio, Luis and Clark, Patricia. (2019). Bone age as a correction factor for the analysis of trabecular bone score (TBS) in children. Archives of Osteoporosis. 14(1), pp. 1 - 7. https://doi.org/10.1007/s11657-019-0573-6
Fracture risk following intermission of osteoporosis therapy
Dennison, Elaine M., Cooper, Cyrus, Kanis, John A., Bruyère, O., Silverman, S., McCloskey, Eugene, Abrahamsen, Bo, Prieto-Alhambra, D. and Ferrari, Serge L.. (2019). Fracture risk following intermission of osteoporosis therapy. Osteoporosis International. 30(9), pp. 1733 - 1743. https://doi.org/10.1007/s00198-019-05002-w
Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years
Watts, Nelson B., Grbic, John T., Binkley, Neil, Papapoulos, Socrates E., Butler, Peter W., Yin, Xiang, Tierney, Antoniette, Wagman, Rachel B. and McClung, Michael. (2019). Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. The Journal of Clinical Endocrinology and Metabolism. 104(6), pp. 2443 - 2452. https://doi.org/10.1210/jc.2018-01965
A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type i procollagen (PINP): A report from the IFCC-IOF Joint Committee for Bone Metabolism
Cavalier, Etienne, Eastell, Richard, Jørgensen, Niklas Rye, Makris, Konstantinos, Tournis, Symeon, Vasikaran, Samuel, Kanis, John A., Cooper, Cyrus, Pottel, Hans and Morris, Howard A.. (2019). A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type i procollagen (PINP): A report from the IFCC-IOF Joint Committee for Bone Metabolism. Clinical Chemistry and Laboratory Medicine. 57(10), pp. 1546 - 1555. https://doi.org/10.1515/cclm-2019-0174
Proceedings of the 2017 Santa Fe Bone Symposium: Insights and emerging concepts in the management of osteoporosis
Lewiecki, E. Michael, Bilezikian, John P., Carey, John J., Dell, Richard M., Gordon, Catherine M., Harris, Steven T., McClung, Michael, Miller, Paul and Rosenblatt, Michael. (2018). Proceedings of the 2017 Santa Fe Bone Symposium: Insights and emerging concepts in the management of osteoporosis. Journal of Clinical Densitometry. 21(1), pp. 3 - 21. https://doi.org/10.1016/j.jocd.2017.10.041
Drug holidays in women treated for postmenopausal osteoporosis
McClung, Michael R.. (2018). Drug holidays in women treated for postmenopausal osteoporosis. Menopause: The Journal of the North American Menopause Society. 25(10), pp. 1152 - 1154. https://doi.org/10.1097/GME.0000000000001141
Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
McClung, Michael, Williams, Gregory C., Hattersley, Gary, Fitzpatrick, Lorraine A., Wang, Yamei and Miller, Paul D.. (2018). Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide. Calcified Tissue International. 102(6), pp. 634 - 634. https://doi.org/10.1007/s00223-018-0390-8
Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016
Fullman, Nancy, Yearwood, Jamal, Abay, Solomon M., Abbafati, Cristiana, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abebe, Zegeye, Abebo, Teshome Abuka, Aboyans, Victor, Abraha, Haftom Niguse, Abreu, Daisy M. X., Abu-Raddad, Laith J., Adane, Akilew Awoke, Adedoyin, Rufus Adesoji, Adetokunboh, Olatunji, Adhikari, Tara Ballav, Afarideh, Mohsen, Afshin, Ashkan, ... Lozano, Rafael. (2018). Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the global burden of disease study 2016. The Lancet. 391(10136), pp. 2236 - 2271. https://doi.org/10.1016/S0140-6736(18)30994-2
Falls predict fractures independently of FRAX probability: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study
Harvey, Nicholas C., Oden, Anders, Orwoll, E., Lapidus, Jodi, Kwok, T., Karlsson, Magnus, Rosengren, Björn E., Ljunggren, Östen, Cooper, Cyrus, McCloskey, Eugene, Kanis, John A., Ohlsson, Claes, Mellström, Dan and Johansson, Helena. (2018). Falls predict fractures independently of FRAX probability: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study. Journal of Bone and Mineral Research. 33(3), pp. 510 - 516. https://doi.org/10.1002/jbmr.3331
Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures—a post hoc analysis of the scoop study
McCloskey, Eugene, Johansson, Helena, Harvey, Nicholas C., Shepstone, L., Lenaghan, E., Fordham, Ric, Harvey, I., Howe, Amanda, Cooper, Cyrus, Clarke, Shane, Gittoes, Neil, Heawood, A., Holland, R., Marshall, Tarnya, O'Neill, T. W., Peters, T. J., Redmond, Niamh, Torgerson, David and Kanis, John A.. (2018). Management of patients with high baseline hip fracture risk by FRAX reduces hip fractures—a post hoc analysis of the scoop study. Journal of Bone and Mineral Research. 33(6), pp. 1020 - 1026. https://doi.org/10.1002/jbmr.3411
Osteoporosis: An overview
McClung, Michael R., Miller, Paul and Papapoulos, Socrates E.. (2018). Osteoporosis: An overview. In In J. P. Bilezikian (Ed.). Primer on the metabolic bone diseases and disorders of mineral metabolism pp. 395 - 397 Wiley-Blackwell. https://doi.org/10.1002/9781119266594.ch49
Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls, and aBMD: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study
Harvey, Nicholas C., Oden, Anders, Orwoll, E., Lapidus, Jodi, Kwok, T., Karlsson, Magnus, Rosengren, Björn E., Ribom, Eva, Cooper, Cyrus, Cawthon, Peggy M., Kanis, John A., Ohlsson, Claes, Mellström, Dan, Johansson, Helena and McCloskey, Eugene. (2018). Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, falls, and aBMD: A meta-analysis of the Osteoporotic Fractures in Men (MrOS) Study. Journal of Bone and Mineral Research. 33(12), pp. 2150 - 2157. https://doi.org/10.1002/jbmr.3556
Pitfalls in the measurement of muscle mass: A need for a reference standard
Buckinx, Fanny, Landi, Francesco, Cesari, Matteo, Fielding, Roger A., Visser, Marjolein, Engelke, Klaus, Maggi, Stefania, Dennison, Elaine, Al-Daghri, Nasser M., Allepaerts, Sophie, Bauer, Jurgen, Bautmans, Ivan, Brandi, Maria Luisa, Bruyère, Olivier, Cederholm, Tommy, Cerreta, Francesca, Cherubini, Antonio, Cooper, Cyrus, Cruz-Jentoft, Alphonso, ... Kanis, John A.. (2018). Pitfalls in the measurement of muscle mass: A need for a reference standard. Journal of Cachexia, Sarcopenia and Muscle. 9(2), pp. 269 - 278. https://doi.org/10.1002/jcsm.12268
Therapeutic approaches to bone protection in adulthood
Curtis, Elizabeth M., McClung, Michael and Compston, Juliet E.. (2018). Therapeutic approaches to bone protection in adulthood. In In N. C. Harvey and C. Cooper (Ed.). Osteoporosis: A lifecourse epidemiology approach to skeletal health pp. 177 - 192 CRC Press. https://doi.org/10.1201/9781351234627
Future therapies
McClung, Michael R.. (2018). Future therapies. In In J. P. Bilezikian (Ed.). Primer on the metabolic bone diseases and disorders of mineral metabolism pp. 603 - 609 Wiley-Blackwell. https://doi.org/10.1002/9781119266594.ch80
Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis
McClung, Michael R., Harvey, Nicholas C., Fitzpatrick, Lorraine A., Miller, Paul D., Hattersley, Gary, Wang, Yamei and Cosman, Felicia. (2018). Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis. Menopause: The Journal of the North American Menopause Society. 25(7), pp. 767-771. https://doi.org/10.1097/GME.0000000000001080
Geography of fracture incidence in postmenopausal women with osteoporosis treated with abaloparatide
McClung, Michael, Williams, Gregory C., Hattersley, Gary, Fitzpatrick, Lorraine A., Wang, Yamei and Miller, Paul. (2018). Geography of fracture incidence in postmenopausal women with osteoporosis treated with abaloparatide. Calcified Tissue International. 102(6), pp. 627 - 633. https://doi.org/10.1007/s00223-017-0375-z
Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double-blind, phase 2, parallel group study
McClung, Michael, Brown, Jacques P., Diez-Perez, Aldolfo, Resch, Heinrich, Caminis, John, Meisner, Paul, Bolognese, Michael A., Goemaere, Stefan, Bone, Henry G., Zanchetta, Jose R., Maddox, Judy, Bray, Sarah and Grauer, Andreas. (2018). Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double-blind, phase 2, parallel group study. Journal of Bone and Mineral Research. 33(8), pp. 1397 - 1406. https://doi.org/10.1002/jbmr.3452
Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension
Cummings, Steven R., Ferrari, Serge L., Eastell, Richard, Gilchrist, Nigel, Beck Jensen, Jens Erik, McClung, Michael, Roux, Christian, Torring, Ove, Valter, Ivo, Wang, Andrea and Brown, Jacques P.. (2018). Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. Journal of Bone and Mineral Research. 33(2), pp. 190 - 198. https://doi.org/10.1002/jbmr.3337
Review of the guideline of the American College of Physicians on the treatment of osteoporosis
Kanis, J. A., Cooper, C., Rizzoli, R. and Reginster, J.-Y.. (2018). Review of the guideline of the American College of Physicians on the treatment of osteoporosis. Osteoporosis International. 29(7), pp. 1505 - 1510. https://doi.org/10.1007/s00198-018-4504-y
Does nutrition play a role in the prevention and management of sarcopenia?
Robinson, S. M., Reginster, J. Y., Rizzoli, R., Shaw, S. C., Kanis, J. A., Bautmans, I., Bischoff-Ferrari, H., Bruyère, O., Cesari, M., Dawson-Hughes, B., Fielding, R. A., Kaufman, J. M., Landi, F., Malafarina, Vincenzo, Rolland, Y., van Loon, L. J., Vellas, B., Visser, M. and Cooper, C.. (2018). Does nutrition play a role in the prevention and management of sarcopenia? Clinical Nutrition. 37(4), pp. 1121 - 1132. https://doi.org/10.1016/j.clnu.2017.08.016
Romosozumab for the treatment of osteoporosis
McClung, Michael. (2018). Romosozumab for the treatment of osteoporosis. Osteoporosis and Sarcopenia. 4(1), pp. 11 - 15. https://doi.org/10.1016/j.afos.2018.03.002
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
Shepstone, L., Lenaghan, E., Cooper, C., Clarke, Shane, Fong-Soe-Khioe, Rebekah, Fordham, R., Gittoes, Neil, Harvey, Ian, Harvey, Nicholas C., Heawood, A., Holland, R., Howe, A., Kanis, John, Marshall, Tarnya, O'Neill, T. W., Peters, T. J., Redmond, Niamh, Torgerson, David, Turner, David and McCloskey, Eugene. (2018). Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. The Lancet. 391(10122), pp. 741 - 747. https://doi.org/10.1016/S0140-6736(17)32640-5
Mind the (treatment) gap: A global perspective on current and future strategies for prevention of fragility fractures
Harvey, N. C., McCloskey, E. V., Mitchell, P. J., Dawson-Hughes, B., Pierroz, D. D., Reginster, J.-Y. Yves, Rizzoli, R., Cooper, C. and Kanis, J. A.. (2017). Mind the (treatment) gap: A global perspective on current and future strategies for prevention of fragility fractures. Osteoporosis International. 28(5), pp. 1507 - 1529. https://doi.org/10.1007/s00198-016-3894-y
Western osteoporosis alliance clinical practice series: Evaluating the balance of benefits and risks of long-term osteoporosis therapies
Hanley, David A., McClung, Michael R., Davison, K. Shawn, Dian, Larry, Harris, Steve T., Miller, Paul D., Lewiecki, E. Michael and Kendler, David L.. (2017). Western osteoporosis alliance clinical practice series: Evaluating the balance of benefits and risks of long-term osteoporosis therapies. American Journal of Medicine. 130(7), pp. 1 - 7. https://doi.org/10.1016/j.amjmed.2017.03.002
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: Research for evidence and a scientific statement from the European society for clinical and economic aspects of osteopo
Cianferotti, Luisella, Bertoldo, Francesco, Bischoff-Ferrari, Heike A., Bruyere, O., Cooper, Cyrus, Cutolo, Maurizio, Kanis, John A., Kaufman, Jean-Marc, Reginster, Jean-Yves, Rizzoli, Rene and Brandi, Maria Luisa. (2017). Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: Research for evidence and a scientific statement from the European society for clinical and economic aspects of osteopo. Endocrine. 56(2), pp. 245 - 261. https://doi.org/10.1007/s12020-017-1290-9
Erratum to: diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO
Pavelka, Karel, Bruyère, O., Cooper, Cyrus, Kanis, John, Leeb, Burkhard F., Maheu, E., Martel-Pelletier, Johanne, Monfort, Jordi, Pelletier, Jean P., Rizzoli, Rene and Reginster, Jean Yves. (2017). Erratum to: diacerein: benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs and Aging. 34(5), pp. 413 - 413. https://doi.org/10.1007/s40266-017-0457-7
Erratum to: can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis
Bruyère, O., Cooper, Cyrus, Arden, Nigel, Branco, J., Brandi, Maria L., Herrero-Beaumont, G., Berenbaum, F., Dennison, Elaine M., Devogelaer, J. P., Hochberg, Marc, Kanis, John, Laslop, A., McAlindon, T., Reiter, Susanne, Richette, P., Rizzoli, Rene and Reginster, Jean Y.. (2017). Erratum to: can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs and Aging. 34(5), pp. 411 - 411. https://doi.org/10.1007/s40266-017-0456-8
International osteoporosis foundation and European calcified tissue society working group. Recommendations for the screening of adherence to oral bisphosphonates
Diez-Perez, Aldolfo, Naylor, K. E., Abrahamsen, Bo, Agnusdei, D., Brandi, Maria L., Cooper, Cyrus, Dennison, Elaine M., Eriksen, E. F., Gold, D. T., Guañabens, N., Hadji, P., Hiligsmann, Mickaël, Horne, R., Josse, R. G., Kanis, John, Obermayer-Pietsch, Barbara, Prieto-Alhambra, D., Reginster, Jean Y., Rizzoli, Rene, ... Eastell, Richard. (2017). International osteoporosis foundation and European calcified tissue society working group. Recommendations for the screening of adherence to oral bisphosphonates. Osteoporosis International. 28(3), pp. 767 - 774. https://doi.org/10.1007/s00198-017-3906-6
Identification and management of patients at increased risk of osteoporotic fracture: Outcomes of an ESCEO expert consensus meeting
Kanis, J. A., Cooper, C., Rizzoli, R., Abrahamsen, B., Al-Daghri, N. M., Brandi, M. L., Cannata-Andia, J., Cortet, B., Dimai, H. P., Ferrari, S., Hadji, P., Harvey, N. C., Kraenzlin, M., Kurth, A., McCloskey, E., Minisola, S., Thomas, T. and Reginster, J.-Y.. (2017). Identification and management of patients at increased risk of osteoporotic fracture: Outcomes of an ESCEO expert consensus meeting. Osteoporosis International. 28(7), pp. 2023 - 2034. https://doi.org/10.1007/s00198-017-4009-0
Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential
McClung, Michael. (2017). Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential. Therapeutic Advances in Musculoskeletal Disease. 9(10), pp. 263 - 270. https://doi.org/10.1177/1759720X17726744
Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG
Hadji, P., Aapro, Matti S., Body, Jean J., Gnant, Michael, Brandi, Maria L., Reginster, Jean Y., Zillikens, M. C., Glüer, C. C., de Villiers, T., Baber, Rod, Roodman, G. David, Cooper, Cyrus, Langdahl, Bente Lomholt, Palacios, Santiago, Kanis, John, Al-Daghri, Nasser M., Nogues, Xavier, Eriksen, Erik F., Kurth, Andreas, ... Coleman, Robert E.. (2017). Management of aromatase inhibitor-associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology. 7, pp. 1 - 12. https://doi.org/10.1016/j.jbo.2017.03.001
Clinical settings in knee osteoarthritis: Pathophysiology guides treatment
Herrero-Beaumont, Gabriel, Roman-Blas, Jorge A., Bruyère, Olivier, Cooper, Cyrus, Kanis, John, Maggi, S., Rizzoli, René and Reginster, Jean-Yves. (2017). Clinical settings in knee osteoarthritis: Pathophysiology guides treatment. Maturitas. 96, pp. 54 - 57. https://doi.org/10.1016/j.maturitas.2016.11.013
Clinical usefulness of bone turnover marker concentrations in osteoporosis
Morris, H. A., Eastell, R., Jorgesen, N. R., Cavalier, E., Vasikaran, S., Chubb, S. A. P., Kanis, J. A., Cooper, C. and Makris, K.. (2017). Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clinica Chimica Acta. 467, pp. 34 - 41. https://doi.org/10.1016/j.cca.2016.06.036
Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis
McClung, Michael, Lippuner, K., Brandi, Maria Luisa, Zanchetta, Jose Ruben, Bone, Henry G., Chapurlat, Roland D., Hans, Didier, Wang, Andrea, Zapalowski, C. and Libanati, Cesar. (2017). Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporosis International. 28(10), pp. 2967 - 2973. https://doi.org/10.1007/s00198-017-4140-y
The FRAX-based Lebanese osteoporosis treatment guidelines: Rationale for a hybrid model
Chakhtoura, M., Leslie, W. D., McClung, M., Cheung, A. M. and El-Hajj Fuleihan, G.. (2017). The FRAX-based Lebanese osteoporosis treatment guidelines: Rationale for a hybrid model. Osteoporosis International. 28(1), pp. 127 - 137. https://doi.org/10.1007/s00198-016-3766-5
Erratum to: identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
Kanis, John, Cooper, Cyrus, Rizzoli, Rene, Abrahamsen, Bo, Al-Daghri, N. M., Brandi, Maria L., Cannata, J. B., Cortet, B., Dimai, Hans P., Ferrari, S., Hadji, P., Harvey, Nicholas C., Kraenzlin, M., Kurth, Andreas, McCloskey, Eugene, Minisola, Salvatore, Thomas, T. and Reginster, Jean Y.. (2017). Erratum to: identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporosis International. 28(11), pp. 3285 - 3286. https://doi.org/10.1007/s00198-017-4161-6
Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases
Lewiecki, E. Michael, Bilezikian, John P., Bukata, Susan V., Camacho, Pauline, Clarke, Bart L., McClung, Michael R., Miller, Paul D. and Shepherd, John. (2017). Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases. Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health. 20(2), pp. 134 - 152. https://doi.org/10.1016/j.jocd.2017.01.001
Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review
Beaudart, Charlotte, Dawson, A., Shaw, S. C., Harvey, Nicholas C., Kanis, John, Binkley, Neil, Reginster, Jean Yves, Chapurlat, R., Chan, D. C., Bruyère, O., Rizzoli, Rene, Cooper, Cyrus and Dennison, Elaine M.. (2017). Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporosis International. 28(6), pp. 1817 - 1833. https://doi.org/10.1007/s00198-017-3980-9
Clinical utility of anti-sclerostin antibodies
McClung, Michael. (2017). Clinical utility of anti-sclerostin antibodies. Bone. 96, pp. 3 - 7. https://doi.org/10.1016/j.bone.2016.12.012
The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF)
Harvey, Nicholas C., Biver, Emmanuel, Kaufman, J,, Bauer, Jürgen M., Branco, J., Brandi, Maria Luisa, Bruyère, O., Coxam, V., Cruz-Jentoft, Alfonso J., Czerwinski, E., Dimai, Hans P., Fardellone, P., Landi, Francesco, Reginster, Jean Yves, Dawson-Hughes, Bess, Kanis, John, Rizzoli, Rene and Cooper, Cyrus. (2017). The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporosis International. 28(2), pp. 447 - 462. https://doi.org/10.1007/s00198-016-3773-6
The 2017 hormone therapy position statement of the North American Menopause Society
Pinkerton, Jo A.V., Aguirre, Fernando S., Blake, Jennifer, Cosman, F., Hodis, Howard, Hoffstetter, Susan, Kaunitz, Andrew M., Kingsberg, Sheryl A., Maki, Pauline M., Manson, JoAnn E., Marchbanks, Polly, McClung, Michael, Nachtigall, Lila E., Nelson, Lawrence M., Pace, Diane T., Reid, Robert L., Sarrel, Phillip M., Shifren, Jan L., Stuenkel, Cynthia A. and Utian, Wulf H.. (2017). The 2017 hormone therapy position statement of the North American Menopause Society. Menopause: The Journal of the North American Menopause Society. 24(7), pp. 728 - 753. https://doi.org/10.1097/GME.0000000000000921
UK clinical guideline for the prevention and treatment of osteoporosis
Compston, Juliet E., Cooper, Alun, Cooper, Cyrus, Gittoes, Neil, Gregson, C., Harvey, Nicholas C., Hope, S., Kanis, John, McCloskey, Eugene, Poole, Kenneth E.S., Reid, David M., Selby, P., Thompson, F., Thurston, A. and Vine, N.. (2017). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis. 12(43), pp. 1 - 24. https://doi.org/10.1007/s11657-017-0324-5
Using osteoporosis therapies in combination
McClung, Michael. (2017). Using osteoporosis therapies in combination. Current Osteoporosis Reports. 15(4), pp. 343 - 352. https://doi.org/10.1007/s11914-017-0376-x
Observations following discontinuation of long-term denosumab therapy
McClung, Michael, Wagman, Rachel B., Miller, Paul, Wang, Andrea and Lewiecki, E M.. (2017). Observations following discontinuation of long-term denosumab therapy. Osteoporosis International. 28(5), pp. 1723 - 1732. https://doi.org/10.1007/s00198-017-3919-1
A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation
Kanis, John A., Harvey, Nicholas C., Cooper, Cyrus, Johansson, Helena, Odén, Anders, McCloskey, Eugene V. and The Advisory Board of the National Osteoporosis Guideline Group. (2016). A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Archives of Osteoporosis. 11, p. Article 25. https://doi.org/10.1007/s11657-016-0278-z
FRAX predicts incident falls in elderly men: findings from MrOs Sweden
Harvey, Nicholas C., Johansson, Helena, Oden, Anders, Karlsson, Magnus, Rosengren, Björn E., Ljunggren, Östen, Cooper, Cyrus, McCloskey, Eugene V., Kanis, John A., Ohlsson, C. and Mellström, Dan. (2016). FRAX predicts incident falls in elderly men: findings from MrOs Sweden. Osteoporosis International. 27(1), pp. 267 - 274. https://doi.org/10.1007/s00198-015-3295-7
Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey
Bruyère, O., Beaudart, Charlotte, Reginster, Jean Yves, Buckinx, F., Schoene, D., Hirani, V., Cooper, Cyrus, Kanis, John, Rizzoli, Rene, McCloskey, Eugene, Cederholm, T., Cruz-Jentoft, Alfonso J. and Freiberger, E.. (2016). Assessment of muscle mass, muscle strength and physical performance in clinical practice: An international survey. European Geriatric Medicine. 7(3), pp. 243 - 246. https://doi.org/10.1016/j.eurger.2015.12.009
A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement
Blain, H., Masud, Tahir, Dargent-Molina, P., Martin, F. C., Rosendahl, E., van der Velde, Nathalie, Bousquet, J., Benetos, A., Cooper, Cyrus, Kanis, John A., Reginster, Jean Yves, Rizzoli, Rene, Cortet, Bernard, Barbagallo, M., Dreinhöfer, K., Vellas, B., Maggi, S., Strandberg, Timo, Alvarez, M. N., ... Treml, J.. (2016). A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement. European Geriatric Medicine. 7(6), pp. 519 - 525. https://doi.org/10.1016/j.eurger.2016.04.012
Bone mineral density and parathyroid hormone as independent risk factors for mortality in community-dwelling older adults: A population-based prospective cohort study in Brazil. The Sao Paulo Ageing & Health (SPAH) study
Domiciano, Diogo S., Machado, Luana G., Lopes, Jaqueline B., Figueiredo, Camille P., Caparbo, Valeria F., Oliveira, Ricardo M., Scazufca, Marcia, McClung, Michael R. and Pereira, Rosa M.R.. (2016). Bone mineral density and parathyroid hormone as independent risk factors for mortality in community-dwelling older adults: A population-based prospective cohort study in Brazil. The Sao Paulo Ageing & Health (SPAH) study. Journal of Bone and Mineral Research. 31(6), pp. 1146 - 1157. https://doi.org/10.1002/jbmr.2795
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
Cosman, F., Gilchrist, N., McClung, Michael R., Foldes, J., de Villiers, T., Santora, A., Leung, A. T., Samanta, S., Heyden, N., McGinnis, J.P., Rosenberg, E. and Denker, A.E.. (2016). A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. Osteoporosis International. 27(1), pp. 377 - 386. https://doi.org/10.1007/s00198-015-3392-7
A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement
Blain, H., Masud, Tahir, Dargent-Molina, P., Martin, F. C., Rosendahl, E., van der Velde, Nathalie, Bousquet, J., Benetos, A., Cooper, Cyrus, Kanis, John, Reginster, Jean Y., Rizzoli, Rene, Cortet, B., Barbagallo, M., Dreinhöfer, K., Vellas, B., Maggi, S., Strandberg, Timo E., Alvarez, M. N., ... Macijauskien, J. (2016). A comprehensive fracture prevention strategy in older adults: the European Union Geriatric Medicine Society (EUGMS) statement. Aging Clinical and Experimental Research. 28(4), pp. 797 - 803. https://doi.org/10.1007/s40520-016-0588-4
Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO
Pavelka, Karel, Bruyère, Olivier, Cooper, Cyrus, Kanis, John A., Leeb, Burkhard F., Maheu, Emmanuel, Martel-Pelletier, Johanne, Monfort, Jordi, Pelletier, Jean-Pierre, Rizzoli, Rene and Reginster, Jean-Yves. (2016). Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs and Aging. 33(2), pp. 75 - 85. https://doi.org/10.1007/s40266-016-0347-4
Vertebral fractures: Clinical importance and management
Kendler, D. L., Bauer, Doug C., Davison, K. S., Dian, L., Hanley, David A., Harris, S. T., McClung, Michael R., Miller, P. D., Schousboe, J. T., Yuen, C. K. and Lewiecki, E. Michael. (2016). Vertebral fractures: Clinical importance and management. American Journal of Medicine. 129(2), pp. 1 - 10. https://doi.org/10.1016/j.amjmed.2015.09.020
A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement
Blain, H., Masud, Tahir, Dargent-Molina, P., Martin, F. C., Rosendahl, E., van der Velde, N., Bousquet, J., Benetos, A., Cooper, Cyrus, Kanis, John A., Reginster, Jean Yves, Rizzoli, R., Cortet, B., Barbagallo, M., Dreinhöfer, K. E., Vellas, B., Maggi, S. and Strandberg, T.. (2016). A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement. Aging Clinical and Experimental Research. 28(4), pp. 797 - 803. https://doi.org/10.1007/s40520-016-0588-4
A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement
Blain, H., Masud, Tahir, Dargent-Molina, P., Martin, F. C., Rosendahl, E., van der Velde, N., Bousquet, J., Benetos, A., Cooper, Cyrus, Kanis, John A., Reginster, Jean Yves, Rizzoli, R., Cortet, B., Barbagallo, M., Dreinhöfer, K. E., Vellas, B., Maggi, S. and Strandberg, T.. (2016). A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement. Journal of Nutrition, Health and Aging. 20(6), pp. 647 - 652. https://doi.org/10.1007/s12603-016-0741-y
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O
Cooper, Cyrus, Bardin, Thomas, Brandi, M. L., Cacoub, Patrice, Caminis, John, Civitelli, Roberto, Cutolo, Maurizio, Dere, Willard, Devogelaer, Jean-Pierre, Diez-Perez, Adolfo, Einhorn, Thomas A., Emonts, Patrick, Ethgen, Olivier, Kanis, John A., Kaufman, Jean-Marc, Kvien, Tore K., Lems, Willem F., McCloskey, Eugene, Miossec, Pierre, ... Reginster, Jean-Yves. (2016). Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O. Aging Clinical and Experimental Research. 28(1), pp. 1 - 16. https://doi.org/10.1007/s40520-015-0522-1
SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture
Kanis, John A., Compston, Juliet, Cooper, Cyrus, Harvey, Nicholas C., Johansson, Helena, Oden, Anders and McCloskey, Eugene V.. (2016). SIGN Guidelines for Scotland: BMD Versus FRAX Versus QFracture. Calcified Tissue International. 98(5), pp. 417 - 425. https://doi.org/10.1007/s00223-015-0092-4
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting
Bruyère, Olivier, Cooper, Cyrus, Pelletier, Jean-Pierre, Maheu, Emmanuel, Rannou, François, Branco, Jaime, Brandi, Maria Luisa, Kanis, John A., Altman, Roy D., Hochberg, Marc C., Martel-Pelletier, Johanne and Reginster, Jean-Yves. (2016). A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Seminars in Arthritis and Rheumatism. 45(4), pp. S3 - S11. https://doi.org/10.1016/j.semarthrit.2015.11.010
Sarcopenia in daily practice: Assessment and management
Beaudart, Charlotte, McCloskey, Eugene, Bruyère, Olivier, Cesari, Matteo, Rolland, Yves, Rizzoli, Rene, de Carvalho, Islène Araujo, Thiyagarajan, Jotheeswaran Amuthavalli, Bautmans, Ivan, Bertière, Marie-Claude, Brandi, Maria Luisa, Al-Daghri, Nasser M., Burlet, Nansa, Cavalier, Etienne, Cerreta, Francesca, Cherubini, Antonio, Fielding, Roger, Gielen, Evelien, Landi, Francesco, ... Cooper, Cyrus. (2016). Sarcopenia in daily practice: Assessment and management. BMC Geriatrics. 16(170), pp. 1 - 10. https://doi.org/10.1186/s12877-016-0349-4
Proceedings of the 2015 Santa Fe Bone Symposium: Clinical applications of scientific advances in osteoporosis and metabolic bone disease
Lewiecki, E. Michael, Baron, Roland, Bilezikian, John P., Gagel, Robert E., Leonard, Mary B., Leslie, William D., McClung, Michael R. and Miller, Paul D.. (2016). Proceedings of the 2015 Santa Fe Bone Symposium: Clinical applications of scientific advances in osteoporosis and metabolic bone disease. United States of America: Elsevier Inc.. pp. 102 - 116 https://doi.org/10.1016/j.jocd.2015.11.003
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, Jean Yves, Cooper, Cyrus, Rizzoli, Rene, Kanis, John A., Appelboom, Geoff, Bautmans, Ivan, Bischoff-Ferrari, Heike A., Boers, Maarten, Brandi, Maria Luisa, Bruyère, Olivier, Cherubini, Antonio, Flamion, Bruno, Fielding, Roger A., Gasparik, Andrea Ildiko, Van Loon, Lucas, McCloskey, Eugene, Mitlak, Bruce, Pilotto, Alberto, Reiter-Niesert, Suzanne, ... Cruz-Jentoft, Alfonso J.. (2016). Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-015-0517-y
Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis
Zebaze, Roger M., Libanati, Cesar, McClung, Michael R., Zanchetta, Jose Ruben, Kendler, David L., Høiseth, Arne, Wang, Andrea, Ghasem-Zadeh, Ali and Seeman, Ego. (2016). Denosumab reduces cortical porosity of the proximal femoral shaft in postmenopausal women with osteoporosis. Journal of Bone and Mineral Research. 31(10), pp. 1827 - 1834. https://doi.org/10.1002/jbmr.2855
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990--2015: a systematic analysis for the Global Burden of Disease Study 2015
Vos, Theo, Allen, Christine, Arora, Megha, Barber, Ryan M., Bhutta, Zulfiqar A., Brown, Alexandria, Carter, Austin, Casey, Daniel C., Charlson, Fiona J., Chen, Alan Z., Coggeshall, Megan, Cornaby, Leslie, Dandona, Lalit, Dicker, Daniel J., Dilegge, Tina, Erskine, Holly E., Ferrari, Alize J., Fitzmaurice, Christina, Fleming, Tom, ... Murray, Christopher J. L.. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990--2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 388(10053), pp. 1545 - 1602. https://doi.org/10.1016/S0140-6736(16)31678-6
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis
Reginster, Jean Yves, Cooper, Cyrus, Hochberg, Marc, Pelletier, Jean Pierre, Rizzoli, R, Kanis, John A., Abadie, Eric, Maheu, E., Brandi, Maria Luisa, Devogelaer, J. P., Branco, J., Herrero-Beaumont, G., D'Hooghe, Pieter and Bruyère, O.. (2015). Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Current Medical Research and Opinion. 31(5), pp. 1041 - 1045. https://doi.org/10.1185/03007995.2015.1027183
Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool
Javaid, M. K., Kyer, C., Mitchell, P. J., Chana, J., Moss, C., Edwards, M. H., McLellan, A. R., Stenmark, J., Pierroz, D. D., Schneider, M. C., Kanis, John A., Akesson, K. and Cooper, Cyrus. (2015). Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool. Osteoporosis International. 26(11), pp. 2573 - 2578. https://doi.org/10.1007/s00198-015-3192-0
Emerging therapies for osteoporosis
McClung, Michael R.. (2015). Emerging therapies for osteoporosis. Endocrinology and Metabolism. 30(4), pp. 429 - 435. https://doi.org/10.3803/EnM.2015.30.4.429
Odanacatib for the treatment of postmenopausal osteoporosis: Development history and design and participant characteristics of LoFT, the Long-term odanacatib Fracture Trial
Bone, Henry G., Dempster, David W., Eisman, John A., Greenspan, S. L., McClung, Michael R., Nakamura, T., Papapoulos, S., Shih, W. J., Rybak-Feiglin, A., Santora, A. C., Verbruggen, Nadia, Leung, A. T. and Lombardi, Antonio. (2015). Odanacatib for the treatment of postmenopausal osteoporosis: Development history and design and participant characteristics of LoFT, the Long-term odanacatib Fracture Trial. Osteoporosis International. 26(2), pp. 699 - 712. https://doi.org/10.1007/s00198-014-2944-6
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice
Harvey, N. C., Glüer, C. C., Binkley, N., McCloskey, E. V., Brandi, M. L., Cooper, C., Kendler, D., Lamy, O., Laslop, A., Camargos, B. M., Reginster, J-Y, Rizzoli, R. and Kanis, J. A.. (2015). Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 78, pp. 216 - 224. https://doi.org/10.1016/j.bone.2015.05.016
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on biomarkers and frailty
Arden, Nigel, Richette, Pascal, Cooper, Cyrus, Bruyère, Olivier, Abadie, Eric, Branco, Jaime, Brandi, Maria Luisa, Berenbaum, Francis, Clerc, Cécile, Dennison, Elaine M., Devogelaer, Jean-Pierre, Hochberg, Marc, D'Hooghe, Pieter, Herrero-Beaumont, Gabriel, Kanis, John A., Laslop, Andrea, Leblanc, Véronique, Maggi, Stefania, Mautone, Giuseppe, ... Reginster, Jean-Yves. (2015). Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on biomarkers and frailty. Drugs and Aging. 32(7), pp. 525 - 535. https://doi.org/10.1007/s40266-015-0276-7
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: Expert consensus statement
Reginster, Jean Yves, Reiter-Niesert, S., Bruyère, O., Berenbaum, F., Brandi, Maria-Luisa, Branco, J., Devogelaer, J.-P., Herrero-Beaumont, G., Kanis, John A., Maggi, S., Maheu, E., Richette, P., Rizzoli, R. and Cooper, C.. (2015). Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: Expert consensus statement. Osteoarthritis and Cartilage. 23(12), pp. 2086 - 2093. https://doi.org/10.1016/j.joca.2015.07.001
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: Results from the ADAMO trial
Langdahl, Bente Lomholt, Teglbjaerg, Christence S., Ho, Pei-Ran, Chapurlat, Roland D., Czerwinski, Edward, Kendler, David L., Reginster, Jean Yves, Kivitz, Alan, Lewiecki, E. Michael, Miller, Paul D., Bolognese, Michael A., McClung, Michael R., Bone, Henry G., Ljunggren, Östen, Abrahamsen, Bo, Gruntmanis, Ugis, Yang, Yu-Ching, Wagman, Rachel B., Mirza, Faisal, ... Orwoll, Eric. (2015). A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: Results from the ADAMO trial. The Journal of Clinical Endocrinology and Metabolism. 100(4), pp. 1335 - 1342. https://doi.org/10.1210/jc.2014-4079
FRAX-based assessment and intervention thresholds - An exploration of thresholds in women aged 50 years and older in the UK
McCloskey, Eugene V., Kanis, John A., Johansson, Helena, Harvey, Nicholas C., Oden, Anders, Cooper, Alun, Cooper, C., Francis, Roger M., Reid, D. M., Marsh, D., Selby, P., Thompson, F., Hewitt, S. and Compston, Juliet E.. (2015). FRAX-based assessment and intervention thresholds - An exploration of thresholds in women aged 50 years and older in the UK. Osteoporosis International. 26(8), pp. 2091 - 2099. https://doi.org/10.1007/s00198-015-3176-0
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis
Bruyère, Olivier, Cooper, Cyrus, Arden, Nigel, Branco, Jaime, Brandi, Maria Luisa, Herrero-Beaumont, Gabriel, Berenbaum, Francis, Dennison, Elaine M., Devogelaer, Jean-Pierre, Hochberg, Marc, Kanis, John A., Laslop, Andrea, McAlindon, Tim, Reiter, Susanne, Richette, Pascal, Rizzoli, Rene and Reginster, Jean-Yves. (2015). Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs and Aging. 32(3), pp. 179 - 187. https://doi.org/10.1007/s40266-015-0243-3
Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology
Zysset, Philippe, Pahr, Dieter, Engelke, Klaus, Genant, Harry K., McClung, Michael R., Kendler, David L., Recknor, Christopher, Kinzl, Michael, Schwiedrzik, Jakob, Museyko, Oleg, Wang, Andrea and Libanati, Cesar. (2015). Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology. Bone. 81(December), pp. 122 - 130. https://doi.org/10.1016/j.bone.2015.06.025
Denosumab rapidly increases cortical bone in key locations of the femur: A 3D bone mapping study in women with osteoporosis
Poole, Kenneth E.S., Treece, Graham M., Gee, Andrew H., Brown, Jacques P., McClung, Michael R., Wang, Andrea and Libanati, Cesar. (2015). Denosumab rapidly increases cortical bone in key locations of the femur: A 3D bone mapping study in women with osteoporosis. Journal of Bone and Mineral Research. 30(1), pp. 46 - 54. https://doi.org/10.1002/jbmr.2325
Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study
Vimaleswaran, Karani S., Cavadino, Alana, Berry, Diane J., Jorde, Rolf, Dieffenbach, Aida Karina, Lu, Chen, Alves, Alexessander Couto, Heerspink, Hiddo J. Lambers, Tikkanen, Emmi, Eriksson, Joel, Wong, Andrew, Mangino, Massimo, Jablonski, Kathleen A., Nolte, Ilja M., Houston, Denise K., Ahluwalia, Tarunveer Singh, van der Most, Peter J., Pasko, Dorota, Zgaga, Lina, ... Hyppönen, Elina. (2014). Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study. The Lancet Diabetes & Endocrinology. 2(9), pp. 719 - 729. https://doi.org/10.1016/S2213-8587(14)70113-5
Creation of an age-adjusted, dual-energy x-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-hispanic US white women
Simonelli, Christine, Leib, Edward, Mossman, Ned, Winzenrieth, Renaud, Hans, Didier and McClung, Michael R.. (2014). Creation of an age-adjusted, dual-energy x-ray absorptiometry-derived trabecular bone score curve for the lumbar spine in non-hispanic US white women. Journal of Clinical Densitometry. 17(2), pp. 314 - 319. https://doi.org/10.1016/j.jocd.2013.09.002
Management of osteoporosis of the oldest old
Rizzoli, R, Branco, J., Brandi, Maria Luisa, Boonen, S., Bruyère, O., Cacoub, P., Cooper, Cyrus, Diez-Perez, A, Duder, J., Fielding, R. A., Harvey, Nicholas C., Hiligsmann, Mickaël, Kanis, John A., Petermans, J., Ringe, J. D., Tsouderos, Y., Weinman, J. and Reginster, Jean Yves. (2014). Management of osteoporosis of the oldest old. Osteoporosis International. 25(11), pp. 2507 - 2529. https://doi.org/10.1007/s00198-014-2755-9
Value of biomarkers in osteoarthritis: Current status and perspectives
Lotz, M., Martel-Pelletier, Johanne, Christiansen, Claus, Brandi, Maria Luisa, Bruyère, O., Chapurlat, Roland D., Collette, J., Cooper, Cyrus, Giacovelli, G., Kanis, John A., Karsdal, M. A., Kraus, V., Lems, Willem F., Meulenbelt, I., Pelletier, Jean Pierre, Raynauld, J. P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., ... Reginster, Jean Yves. (2014). Value of biomarkers in osteoarthritis: Current status and perspectives. Postgraduate Medical Journal. 90(1061), pp. 171 - 178. https://doi.org/10.1136/postgradmedj-2013-203726rep
A meta-analysis of reference markers of bone turnover for prediction of fracture
Johansson, Helena, Oden, Anders, Kanis, John A., McCloskey, Eugene V., Morris, Howard A., Cooper, Cyrus and Vasikaran, Samuel. (2014). A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcified Tissue International. 94(5), pp. 560 - 567. https://doi.org/10.1007/s00223-014-9842-y
Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab
Keaveny, Tony M., McClung, Michael R., Genant, Harry K., Zanchetta, Jose Ruben, Kendler, David, Brown, Jacques P., Goemaere, Stefan, Recknor, Christopher, Brandi, Maria Luisa, Eastell, Richard, Kopperdahl, David L., Engelke, Klaus, Fuerst, Thomas, Radcliffe, Hoi-Shen and Libanati, Cesar. (2014). Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab. Journal of Bone and Mineral Research. 29(1), pp. 158 - 165. https://doi.org/10.1002/jbmr.2024
The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Rizzoli, Rene, Stevenson, John C., Bauer, Jürgen M., Van Loon, Lucas J.C., Walrand, Stéphane, Kanis, John A., Cooper, Cyrus, Brandi, Maria Luisa, Diez-Perez, Adolfo and Reginster, Jean Yves. (2014). The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 79(1), pp. 122 - 132. https://doi.org/10.1016/j.maturitas.2014.07.005
Epidemiological burden of postmenopausal osteoporosis in Italy from 2010 to 2020: Estimations from a disease model
Piscitelli, P., Brandi, M., Cawston, H., Gauthier, A., Kanis, J. A., Compston, J., Borgstrom, F., Cooper, C. and McCloskey, E.. (2014). Epidemiological burden of postmenopausal osteoporosis in Italy from 2010 to 2020: Estimations from a disease model. Calcified Tissue International. 95(5), pp. 419 - 427. https://doi.org/10.1007/s00223-014-9910-3
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Bruyère, Olivier, Cooper, Cyrus, Pelletier, Jean-Pierre, Branco, Jaime, Brandi, Maria Luisa, Guillemin, Francis, Hochberg, Marc C., Kanis, John A., Kvien, Tore K., Martel-Pelletier, Johanne, Rizzoli, Rene, Silverman, Stuart and Reginster, Jean-Yves. (2014). An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism. 44(3), pp. 253 - 263. https://doi.org/10.1016/j.semarthrit.2014.05.014
Challenges for the development of bone-forming agents in Europe
Kanis, John A., Rizzoli, Rene, Cooper, Cyrus and Reginster, Jean-Yves. (2014). Challenges for the development of bone-forming agents in Europe. Calcified Tissue International. 94(5), pp. 469 - 473. https://doi.org/10.1007/s00223-014-9844-9
Bone safety with risedronate: histomorphometric studies at different dose levels and exposure
Recker, Robert R., SteMarie, L.-G., Chavassieux, P., McClung, Michael R. and Lundy, M. W.. (2014). Bone safety with risedronate: histomorphometric studies at different dose levels and exposure. Osteoporosis International. 26(1), pp. 327 - 337. https://doi.org/10.1007/s00198-014-2850-y
Romosozumab in postmenopausal women with low bone mineral density
McClung, Michael R., Grauer, Andreas, Boonen, Steven and Bolognese, Michael A.. (2014). Romosozumab in postmenopausal women with low bone mineral density. New England Journal of Medicine. 370(5), pp. 412 - 420. https://doi.org/10.1056/NEJMoa1305224
A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Hiligsmann, Mickaël, Cooper, Cyrus, Guillemin, Francis, Hochberg, Marc C., Tugwell, Peter, Arden, Nigel, Berenbaum, Francis, Boers, Maarten, Boonen, Annelies, Branco, Jaime C., Maria-Luisa, Brandi, Bruyère, Olivier, Gasparik, Andrea Ildiko, Kanis, John A., Kvien, Tore K., Martel-Pelletier, Johanne, Pelletier, Jean-Pierre, Pinedo-Villanueva, Rafael, Pinto, Daniel, ... Reginster, Jean-Yves. (2014). A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism. 44(3), pp. 271 - 282. https://doi.org/10.1016/j.semarthrit.2014.06.005
Genetic determinants of heel bone properties: Genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium
Moayyeri, Alireza, Hsu, Yi-Hsiang, Karasik, David, Estrada, Karol, Xiao, Su-Mei, Nielson, Carrie, Srikanth, Priya, Giroux, Sylvie, Wilson, Scott G., Zheng, Hou-Feng, Smith, Albert V., Pye, Stephen R., Leo, Paul J., Teumer, Alexander, Hwang, Joo-Yeon, Ohlsson, Claes, McGuigan, Fiona, Minster, Ryan L., Hayward, Caroline, ... Kaptoge, Stephen K.. (2014). Genetic determinants of heel bone properties: Genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Human Molecular Genetics. 23(11), pp. 3054 - 3068. https://doi.org/10.1093/hmg/ddt675
Worldwide uptake of FRAX
Kanis, John A., Johansson, Helena, Oden, Anders, Cooper, Cyrus, McCloskey, Eugene E. V., Epidemiology and Quality of Life Working Group of IOF, and Epidemiology and Quality of Life Working Group of IOF. (2014). Worldwide uptake of FRAX. Archives of Osteoporosis. 9(1), pp. 1 - 10. https://doi.org/10.1007/s11657-013-0166-8
Gaucher disease and bone manifestations
Marcucci, Gemma, Zimran, Ari, Bembi, Bruno, Kanis, John, Reginster, Jean-Yves, Rizzoli, Rene, Cooper, Cyrus and Brandi, Maria Luisa. (2014). Gaucher disease and bone manifestations. Calcified Tissue International. 95(6), pp. 477 - 494. https://doi.org/10.1007/s00223-014-9923-y
Tibolone
McClung, M. R.. (2013). Tibolone. In In Genazzani, Andrea R. (Ed.). Postmenopausal osteoporosis : Hormones and other therapies pp. 233-238 Taylor & Francis. https://doi.org/10.1201/b14631-28
Treatment of osteoporosis in men
Kaufman, J-M, Reginster, J-Y, Boonen, S., Brandi, M. L., Cooper, Cyrus, Dere, W., Devogelaer, J. P., Diez-Perez, A, Kanis, John A., McCloskey, Eugene, Mitlak, B., Orwoll, E, Ringe, J. D., Weryha, G. and Rizzoli, R. (2013). Treatment of osteoporosis in men. Bone. 53(1), pp. 134 - 144. https://doi.org/10.1016/j.bone.2012.11.018
Value of biomarkers in osteoarthritis: Current status and perspectives
Lotz, M., Martel-Pelletier, Johanne, Christiansen, Claus, Brandi, Maria-Luisa, Bruyère, O., Chapurlat, Roland D., Collette, J., Cooper, Cyrus, Giacovelli, G., Kanis, John A., Karsdal, M. A., Kraus, V., Lems, Willem F., Meulenbelt, I., Pelletier, Jean-Pierre, Raynauld, J.-P., Reiter-Niesert, S., Rizzoli, R., Sandell, L. J., ... Reginster, Jean-Yves. (2013). Value of biomarkers in osteoarthritis: Current status and perspectives. Annals of the Rheumatic Diseases. 72(11), pp. 1756 - 1763. https://doi.org/10.1136/annrheumdis-2013-203726
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
Compston, J., Bowring, C., Cooper, A., Cooper, C., Davies, C., Francis, R., Kanis, J. A., Marsh, D., McCloskey, E. V., Reid, D. M. and Selby, P.. (2013). Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas. 75(4), pp. 392 - 396. https://doi.org/10.1016/j.maturitas.2013.05.013
Quality of life in sarcopenia and frailty
Rizzoli, Rene, Reginster, Jean-Yves, Arnal, Jean-Francois, Bautmans, Ivan, Beaudart, Charlotte, Bischoff-Ferrari, Heike, Biver, Emmanuel, Boonen, Steven, Brandi, Maria-Luisa, Chines, Arkadi, Cooper, Cyrus, Epstein, Sol, Fielding, Roger A., Goodpaster, Bret, Kanis, John A., Kaufman, J., Laslop, A., Malafarina, Vincenzo, Mañas, Leocadio Rodriguez, ... Bruyère, O.. (2013). Quality of life in sarcopenia and frailty. Calcified Tissue International. 93(2), pp. 101 - 120. https://doi.org/10.1007/s00223-013-9758-y
Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Rizzoli, R., Boonen, S., Brandi, Maria-Luisa, Bruyère, O., Cooper, Cyrus, Kanis, John A., Kaufman, J.-M., Ringe, J. D., Weryha, G. and Reginster, Jean Yves. (2013). Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion. 29(4), pp. 305 - 313. https://doi.org/10.1185/03007995.2013.766162
Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday
McClung, Michael R., Harris, Steven T., Miller, Paul D., Bauer, Doug C., Davison, K. Shawn, Dian, Larry, Hanley, David A., Kendler, David L., Yuen, Chui Kin and Lewiecki, E. Michael. (2013). Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday. American Journal of Medicine. 126(1), pp. 13 - 20. https://doi.org/10.1016/j.amjmed.2012.06.023
A novel monthly dosing regimen of risedronate for the treatment of postmenopausal Osteoporosis: 2-year data
McClung, Michael R., Benhamou, Claude-Laurent, Man, Zulema, Tlustochowicz, Witold, Zanchetta, Jose Ruben, Eusebio, Rachelle, Balske, Ana M., Matzkin, Ellen, Olszynski, Wojciech P., Recker, Robert R. and Delmas, Pierre D.. (2013). A novel monthly dosing regimen of risedronate for the treatment of postmenopausal Osteoporosis: 2-year data. Calcified Tissue International. 92(1), pp. 59 - 67. https://doi.org/10.1007/s00223-012-9668-4
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: Bone density, mass, and strength of the radius, and wrist fracture
Simon, James A., Recknor, Christopher, Moffett, Alfred H., Adachi, Jonathan D., Franek, Edward, Lewiecki, E. Michael, McClung, Michael R., Mautalen, Carlos A., Ragi-Eis, Sergio, Nicholson, Geoffrey Charles, Muschitz, Christian, Nuti, Ranuccio, Torring, Ove, Wang, Andrea and Libanati, Cesar. (2013). Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: Bone density, mass, and strength of the radius, and wrist fracture. Menopause. 20(2), pp. 130 - 137. https://doi.org/10.1097/gme.0b013e318267f909
Health technology assessment in osteoporosis
Hiligsmann, Mickaël, Kanis, John A., Compston, Juliet, Cooper, Cyrus, Flamion, Bruno, Bergmann, Pierre, Body, Jean-Jaques, Boonen, Steven, Bruyère, Olivier, Devogelaer, Jean-Pierre, Goemaere, Stefan, Kaufman, Jean-Marc, Rozenberg, Serge and Reginster, Jean-Yves. (2013). Health technology assessment in osteoporosis. Calcified Tissue International. 93(1), pp. 1 - 14. https://doi.org/10.1007/s00223-013-9724-8
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
McClung, Michael R., Zanchetta, Jose Ruben, Racewicz, A., Roux, Christian, Benhamou, Claude-Laurent, Man, Zulema, Eusebio, Rachelle, Beary, J. F., Burgio, D.E., Matzkin, Ellen, Boonen, Steven and Delmas, P. D.. (2013). Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. Osteoporosis International. 24(1), pp. 293 - 299. https://doi.org/10.1007/s00198-012-2056-0
Health economics in the field of osteoarthritis: An expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Hiligsmann, Mickaël, Cooper, Cyrus, Arden, Nigel, Boers, Maarten, Branco, Jaime C., Brandi, Maria Luisa, Bruyère, Olivier, Guillemin, Francis, Hochberg, Marc C., Hunter, David J., Kanis, John A., Kvien, Tore K., Laslop, Andrea, Pelletier, Jean-Pierre, Pinto, Daniel, Reiter-Niesert, Susanne, Rizzoli, Rene, Rovati, Lucio C., Severens, Johan L., ... Reginster, Jean-Yves. (2013). Health economics in the field of osteoarthritis: An expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism. 43(3), pp. 303 - 313. https://doi.org/10.1016/j.semarthrit.2013.07.003
Osteoporosis in the European Union: A compendium of country-specific reports
Svedbom, A., Hernlund, E., Ivergård, M., Compston, Juliet E., Cooper, Cyrus, Stenmark, J., McCloskey, Eugene V., Jönsson, Bengt, Kanis, John A., The EU review panel of the IOF, and The EU review panel of the IOF. (2013). Osteoporosis in the European Union: A compendium of country-specific reports. Archives of Osteoporosis. 8(1-2), pp. 1 - 218. https://doi.org/10.1007/s11657-013-0137-0
Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
McClung, Michael R., Balske, Ana M., Burgio, D. E., Wenderoth, D. and Recker, Robert R.. (2013). Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years. Osteoporosis International. 24(1), pp. 301 - 310. https://doi.org/10.1007/s00198-012-2175-7
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: A randomized, double-Blind, placebo-controlled study
Bone, Henry G., Lindsay, Robert, McClung, Michael R., Perez, Alfonso T., Raanan, Marsha G. and Spanheimer, Robert G.. (2013). Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: A randomized, double-Blind, placebo-controlled study. The Journal of Clinical Endocrinology and Metabolism. 98(12), pp. 4691 - 4701. https://doi.org/10.1210/jc.2012-4096
How to define responders in osteoarthritis
Cooper, Cyrus, Adachi, Jonathan D., Bardin, Thomas, Berenbaum, Francis, Flamion, Bruno, Jonsson, Helgi, Kanis, John A., Pelousse, Franz, Lems, Willem F., Pelletier, Jean-Pierre, Martel-Pelletier, Johanne, Reiter, Susanne, Reginster, Jean-Yves, Rizzoli, Rene and Bruyère, Olivier. (2013). How to define responders in osteoarthritis. Current Medical Research and Opinion. 29(6), pp. 719 - 729. https://doi.org/10.1185/03007995.2013.792793
Controversies in osteoporosis management: Concerns about bisphosphonates and when are "drug holidays" required?
McClung, Michael R.. (2013). Controversies in osteoporosis management: Concerns about bisphosphonates and when are "drug holidays" required? Clinical Obstetrics and Gynecology. 56(4), pp. 743 - 748. https://doi.org/10.1097/GRF.0b013e3182a98295
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, John A., McCloskey, Eugene V., Johansson, Helena, Cooper, Cyrus, Rizzoli, R. and Reginster, Jean Yves. (2013). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International. 24(1), pp. 23 - 57. https://doi.org/10.1007/s00198-012-2074-y
Tools in the assessment of sarcopenia
Cooper, C., Fielding, R., Visser, M., Van Loon, L. J., Rolland, Y., Orwoll, E., Reid, K., Boonen, S., Dere, W., Epstein, S., Mitlak, B., Tsouderos, Y., Sayer, A. A., Rizzoli, R., Reginster, J. Y. and Kanis, J. A.. (2013). Tools in the assessment of sarcopenia. Calcified Tissue International. 93(3), pp. 201 - 210. https://doi.org/10.1007/s00223-013-9757-z
Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis
McClung, Michael R., Zanchetta, Jose Ruben, Høiseth, Arne, Kendler, David L., Yuen, Chui Kin, Brown, Jacques P., Stonkus, Sigtas, Goemaere, Stefan, Recknor, Christopher, Woodson, Grattan C., Bolognese, Michael A., Franek, Edward, Brandi, Maria Luisa, Wang, Andrea and Libanati, Cesar. (2013). Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis. Journal of Clinical Densitometry. 16(2), pp. 250 - 256. https://doi.org/10.1016/j.jocd.2012.02.014
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
McClung, Michael R., Lewiecki, E. Michael, Geller, M. L. and Bolognese, Michael A.. (2013). Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial. Osteoporosis International. 24(1), pp. 227 - 235. https://doi.org/10.1007/s00198-012-2052-4
Osteoporosis in the European Union: Medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation IOF and the European Federation of Pharmaceutical Industry Associations EFPIA
Hernlund, E., Svedbom, A., Ivergård, M., Compston, Juliet E., Cooper, Cyrus, Stenmark, J., McCloskey, Eugene V., Jönsson, Bengt and Kanis, John A.. (2013). Osteoporosis in the European Union: Medical management, epidemiology and economic burden: A report prepared in collaboration with the International Osteoporosis Foundation IOF and the European Federation of Pharmaceutical Industry Associations EFPIA. Archives of Osteoporosis. 8(1-2), pp. 1 - 115. https://doi.org/10.1007/s11657-013-0136-1
Standardising the descriptive epidemiology of osteoporosis: Recommendations from the Epidemiology and Quality of Life Working Group of IOF
Kanis, John A., Adachi, Jonathan D., Cooper, Cyrus, Clark, P., Cummings, Steven R., Diaz-Curiel, M., Harvey, Nicholas C., Hiligsmann, Mickaël, Papaioannou, A., Pierroz, D. D., Silverman, S. L. and Szulc, P.. (2013). Standardising the descriptive epidemiology of osteoporosis: Recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporosis International. 24(11), pp. 2763 - 2764. https://doi.org/10.1007/s00198-013-2413-7
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?
Pelletier, Jean Pierre, Cooper, Cyrus, Peterfy, C., Reginster, Jean Yves, Brandi, Maria Luisa, Bruyère, O., Chapurlat, Roland D., Cicuttini, Flavia, Conaghan, P. G., Doherty, M., Genant, H., Giacovelli, G., Hochberg, Marc, Hunter, David J., Kanis, John A., Kloppenburg, M., Laredo, J. D., McAlindon, T., Nevitt, M., ... Guermazi, A.. (2013). What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Annals of the Rheumatic Diseases. 72(10), pp. 1594 - 1604. https://doi.org/10.1136/annrheumdis-2013-203631
A systematic review of hip fracture incidence and probability of fracture worldwide
Kanis, John A., Oden, Anders, McCloskey, Eugene V., Johansson, Helena, Wahl, D. A. and Cooper, Cyrus. (2012). A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis International. 23(9), pp. 2239 - 2256. https://doi.org/10.1007/s00198-012-1964-3
In Memoriam: Sergio Ragi-Eis, MD
McClung, Michael. (2012). In Memoriam: Sergio Ragi-Eis, MD. Archives of Osteoporosis. 7(43862), pp. 1 - 2. https://doi.org/10.1007/s11657-012-0081-4
Effect of denosumab treatment on the risk of fractures in subgroupsof women with postmenopausal osteoporosis
McClung, Michael R., Boonen, Steven, Torring, Ove, Roux, Christian, Rizzoli, Rene, Bone, Henry G., Benhamou, Claude-Laurent, Lems, Willem F., Minisola, Salvatore, Halse, Johan, Hoeck, Hans C., Eastell, Richard, Wang, Andrea, Siddhanti, Suresh and Cummings, Steven R.. (2012). Effect of denosumab treatment on the risk of fractures in subgroupsof women with postmenopausal osteoporosis. Journal of Bone and Mineral Research. 27(1), pp. 211 - 218. https://doi.org/10.1002/jbmr.536
In memoriam: Sergio Ragi-Eis, MD
McClung, Michael R.. (2012). In memoriam: Sergio Ragi-Eis, MD. Journal of Clinical Densitometry. 23(6), pp. 1651 - 1652. https://doi.org/10.1007/s00198-012-1980-3
Long-term treatment of osteoporosis in postmenopausal women: A review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
Cooper, Cyrus, Reginster, Jean-Yves, Cortet, B., Diaz-Curiel, M., Lorenc, R. S., Kanis, John A. and Rizzoli, R.. (2012). Long-term treatment of osteoporosis in postmenopausal women: A review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Current Medical Research and Opinion. 28(3), pp. 475 - 491. https://doi.org/10.1185/03007995.2012.663750
Antidepressant medications and osteoporosis
Rizzoli, R., Cooper, C., Reginster, Jean Yves, Abrahamsen, Bo, Adachi, Jonathan, Brandi, Maria Luisa, Bruyère, O., Compston, Juliet E., Ducy, P., Ferrari, S., Harvey, Nicholas C., Kanis, John A., Karsenty, G., Laslop, A., Rabenda, V. and Vestergaard, P.. (2012). Antidepressant medications and osteoporosis. Bone. 51(3), pp. 606 - 613. https://doi.org/10.1016/j.bone.2012.05.018
Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: Estimations from a disease model
Cawston, H., Maravic, M., Fardellone, P., Gauthier, A., Kanis, John A., Compston, Juliet E., Borgström, F., Cooper, Cyrus and McCloskey, Eugene. (2012). Epidemiological burden of postmenopausal osteoporosis in France from 2010 to 2020: Estimations from a disease model. Archives of Osteoporosis. 7(2017-02-01), pp. 237 - 246. https://doi.org/10.1007/s11657-012-0102-3
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
Lekamwasam, S., Adachi, Jonathan D., Agnusdei, D., Bilezikian, J. P., Boonen, S., Borgström, F., Cooper, Cyrus, Diez-Perez, A., Eastell, Richard, Hofbauer, L. C., Kanis, John A., Langdahl, B. L., Lesnyak, Olga, Lorenc, R. S., McCloskey, Eugene, Messina, O. D., Napoli, N., Obermayer-Pietsch, B., Ralston, Stuart H., ... Compston, Juliet E.. (2012). A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporosis International. 23(9), pp. 2257 - 2276. https://doi.org/10.1007/s00198-012-1958-1
In memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962-February 22, 2012)
Bilezikian, John P., Zerbini, Cristiano, Lewiecki, E. Michael, Borges, Joao Lindolfo, Miller, Paul D., Hans, Didier, Camargos, Bruno Muzzi and McClung, Michael R.. (2012). In memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962-February 22, 2012). Osteoporosis International. 15(3), pp. 257 - 259. https://doi.org/10.1016/j.jocd.2012.05.003
Burden of postmenopausal osteoporosis in Germany: Estimations from a disease model
Gauthier, A., Kanis, John A., Jiang, Yling, Dreinhöfer, K., Martin, M., Compston, Juliet E., Borgström, F., Cooper, Cyrus and McCloskey, Eugene. (2012). Burden of postmenopausal osteoporosis in Germany: Estimations from a disease model. Archives of Osteoporosis. 7(2017-02-01), pp. 209 - 218. https://doi.org/10.1007/s11657-012-0099-7
Revisiting the prevention of bone loss at menopause
McClung, Michael R.. (2012). Revisiting the prevention of bone loss at menopause. Menopause. 19(11), pp. 1173 - 1175. https://doi.org/10.1097/gme.0b013e318274fb1d
A reappraisal of generic bisphosphonates in osteoporosis
Kanis, John A., Reginster, Jean Yves, Kaufman, J.-M., Ringe, J.-D., Adachi, Jonathan D., Hiligsmann, Mickaël, Rizzoli, R. and Cooper, Cyrus. (2012). A reappraisal of generic bisphosphonates in osteoporosis. Osteoporosis International. 23(1), pp. 213 - 221. https://doi.org/10.1007/s00198-011-1796-6
Femoral strength in osteoporotic women treated with teriparatide or alendronate
Keaveny, Tony M., McClung, Michael R., Wan, Xiaohai, Kopperdahl, David L., Mitlak, Bruce H. and Krohn, Kelly. (2012). Femoral strength in osteoporotic women treated with teriparatide or alendronate. Bone. 50(1), pp. 165 - 170. https://doi.org/10.1016/j.bone.2011.10.002
Management of glucocorticoid-induced osteoporosis
Rizzoli, R., Adachi, J. D., Cooper, C., Dere, W., Devogelaer, J. P., Diez-Perez, A., Kanis, J. A., Laslop, A., Mitlak, B., Papapoulos, S., Ralston, S., Reiter, S., Werhya, G. and Reginster, J. Y.. (2012). Management of glucocorticoid-induced osteoporosis. Calcified Tissue International. 91(4), pp. 225 - 243. https://doi.org/10.1007/s00223-012-9630-5
Vitamin D with calcium reduces mortality: Patient level pooled analysis of 70,528 patients from eight major vitamin D trials
Rejnmark, Lars, Avenell, Alison, Masud, Tahir, Anderson, Frazer, Meyer, Haakon E., Sanders, Kerrie M., Salovaara, Kari, Cooper, Cyrus, Smith, Helen E., Jacobs, Elizabeth T., Torgerson, David, Jackson, Rebecca D., Manson, JoAnn E., Brixon, Kim, Mosekilde, Leif, Robbins, John A., Francis, Roger M. and Abrahamsen, Bo. (2012). Vitamin D with calcium reduces mortality: Patient level pooled analysis of 70,528 patients from eight major vitamin D trials. The Journal of Clinical Endocrinology and Metabolism. 97(8), pp. 2670 - 2681. https://doi.org/10.1210/jc.2011-3328
An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
Lekamwasam, S., Adachi, Jonathan D., Agnusdei, D., Bilezikian, J P., Boonen, S., Borgström, F., Cooper, Cyrus, Perez, A. Diez, Eastell, Richard, Hofbauer, L. C., Kanis, John A., Langdahl, B. L., Lesnyak, Olga, Lorenc, R. S., McCloskey, Eugene, Messina, O. D., Napoli, N., Obermayer-Pietsch, B., Ralston, Stuart H., ... Compston, Juliet E.. (2012). An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Archives of Osteoporosis. 7(2017-02-01), pp. 25 - 30. https://doi.org/10.1007/s11657-012-0070-7
A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: Rationale, design and methods for the SCOOP study
Shepstone, L., Fordham, R., Lenaghan, E., Harvey, I., Cooper, Cyrus, Gittoes, Neil, Heawood, A., Peters, T. J., O¿Neill, T. W., Torgerson, David, Holland, R., Howe, A., Marshall, T., Kanis, John A. and McCloskey, Eugene. (2012). A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of screening older women for the prevention of fractures: Rationale, design and methods for the SCOOP study. Osteoporosis International. 23(10), pp. 2507 - 2515. https://doi.org/10.1007/s00198-011-1876-7
Frailty and sarcopenia: Definitions and outcome parameters
Cooper, Cyrus, Dere, W., Evans, William J., Kanis, John A., Rizzoli, R, Sayer, A. A., Sieber, C. C., Kaufman, J, Van Kan, G. Abellan, Boonen, S., Adachi, Jonathan, Mitlak, B., Tsouderos, Y., Rolland, Y. and Reginster, Jean Yves. (2012). Frailty and sarcopenia: Definitions and outcome parameters. Osteoporosis International. 23(7), pp. 1839 - 1848. https://doi.org/10.1007/s00198-012-1913-1
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
Eisman, John A., Bone, Henry G., Hosking, David J., McClung, Michael R., Reid, Ian R., Rizzoli, Rene, Resch, Heinrich, Verbruggen, Nadia, Hustad, Carolyn M., DaSilva, Carolyn, Petrovic, Romana, Santora, Arthur C., Ince, B. Avery and Lombardi, Antonio. (2011). Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect. Journal of Bone and Mineral Research. 26(2), pp. 242 - 251. https://doi.org/10.1002/jbmr.212
Subtrochanteric fractures after long-term treatment with bisphosphonates: A European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
Rizzoli, R, Åkesson, K., Bouxsein, M. L., Kanis, John A., Napoli, N., Papapoulos, S., Reginster, Jean Yves and Cooper, Cyrus. (2011). Subtrochanteric fractures after long-term treatment with bisphosphonates: A European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporosis International. 22(2), pp. 373 - 390. https://doi.org/10.1007/s00198-010-1453-5
Interpretation and use of FRAX in clinical practice
Kanis, John A., Hans, D., Cooper, Cyrus, Baim, Sanford, Bilezikian, J. P., Binkley, Neil, Cauley, Jane A., Compston, Juliet E., Dawson-Hughes, Bess, Fuleihan, Ghada El-Hajj, Johansson, Helena, Leslie, William D., Lewiecki, E. Michael, Luckey, Marjorie M., Oden, Anders, Papapoulos, S., Poiana, Catalina, Rizzoli, R, Wahl, D. A. and McCloskey, Eugene. (2011). Interpretation and use of FRAX in clinical practice. Osteoporosis International. 22(9), pp. 2395 - 2411. https://doi.org/10.1007/s00198-011-1713-z
Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: Estimations from a disease model
Gauthier, A., Kanis, John A., Jiang, Yling, Martin, M., Compston, Juliet E., Borgström, F., Cooper, Cyrus and McCloskey, Eugene. (2011). Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: Estimations from a disease model. Archives of Osteoporosis. 6(2017-02-01), pp. 179 - 188. https://doi.org/10.1007/s11657-011-0063-y
Joint official positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice
Hans, Dieder B. L., Kanis, John A., Baim, Sanford, Bilezikian, John P., Binkley, Neil, Cauley, Jane A., Compston, Juliet E., Cooper, Cyrus, Dawson-Hughes, Bess, El-Hajj Fuleihan, Ghada, Leslie, William D., Lewiecki, E. Michael, Luckey, Marjorie M., McCloskey, Eugene V., Papapoulos, Socrates E., Poiana, Catalina and Rizzoli, Rene. (2011). Joint official positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice. Journal of Clinical Densitometry. 14(3), pp. 171 - 180. https://doi.org/10.1016/j.jocd.2011.05.007
Development and validation of a disease model for postmenopausal osteoporosis
Gauthier, A., Kanis, John A., Martin, M., Compston, Juliet E., Borgström, F., Cooper, Cyrus and McCloskey, Eugene. (2011). Development and validation of a disease model for postmenopausal osteoporosis. Osteoporosis International. 22(3), pp. 771 - 780. https://doi.org/10.1007/s00198-010-1358-3
Effects of denosumab on fracture and bone mineral density by level of kidney function
Jamal, Sophie A., Ljunggren, Östen, Stehman-Breen, Catherine, Cummings, Steven R., McClung, Michael R., Goemaere, Stefan, Ebeling, Peter R., Franek, Edward, Yang, Yu-ching, Egbuna, Ogo I., Boonen, Steven and Miller, Paul D.. (2011). Effects of denosumab on fracture and bone mineral density by level of kidney function. Journal of Bone and Mineral Research. 26(8), pp. 1829 - 1835. https://doi.org/10.1002/jbmr.403
Partial adherence: A new perspective on health economic assessment in osteoporosis
Kanis, John A., Cooper, Cyrus, Hiligsmann, Mickaël, Rabenda, V., Reginster, Jean-Yves and Rizzoli, R.. (2011). Partial adherence: A new perspective on health economic assessment in osteoporosis. Osteoporosis International. 22(10), pp. 2565 - 2573. https://doi.org/10.1007/s00198-011-1668-0
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
Eastell, Richard, Christiansen, Claus, Grauer, Andreas, Kutilek, Stepan, Libanati, Cesar, McClung, Michael R., Reid, Ian R., Resch, Heinrich, Siris, Ethel, Uebelhart, Daniel, Wang, Andrea, Weryha, Georges and Cummings, Steven R.. (2011). Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. Journal of Bone and Mineral Research. 26(3), pp. 530 - 537. https://doi.org/10.1002/jbmr.251
Osteoporosis: Burden, health care provision and opportunities in the EU
Ström, O., Borgström, F., Kanis, John A., Compston, Juliet E., Cooper, Cyrus, McCloskey, Eugene V. and Jönsson, B.. (2011). Osteoporosis: Burden, health care provision and opportunities in the EU. Archives of Osteoporosis. 6(42767), pp. 59 - 155. https://doi.org/10.1007/s11657-011-0060-1
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis
Rizzoli, Rene, Reginster, Jean-Yves, Boonen, Steven, Bréart, Gérard, Diez-Perez, Adolfo, Felsenberg, Dieter, Kaufman, Jean-Marc, Kanis, John A. and Cooper, Cyrus. (2011). Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcified Tissue International. 89(2), pp. 91 - 104. https://doi.org/10.1007/s00223-011-9499-8
Osteoporosis update from the 2010 Santa Fe Bone Symposium
Lewiecki, E. Michael, Bilezikian, John P., Khosla, Sundeep, Marcus, Robert, McClung, Michael R., Miller, Paul D., Watts, Nelson B. and Maricic, Michael. (2011). Osteoporosis update from the 2010 Santa Fe Bone Symposium. Journal of Clinical Densitometry. 14(1), pp. 1 - 21. https://doi.org/10.1016/j.jocd.2010.12.001
Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk
Boonen, Steven, Adachi, Jonathan D., Man, Zulema, Cummings, Steven R., Lippuner, K., Torring, Ove, Gallagher, J.C., Farrerons, J., Wang, Andrea, Franchimont, N., San Martin, Javier, Grauer, Andreas and McClung, Michael R.. (2011). Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. The Journal of Clinical Endocrinology and Metabolism. 96(6), pp. 1727 - 1736. https://doi.org/10.1210/jc.2010-2784
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards
Vasikaran, Samuel, Eastell, Richard, Bruyere, O., Foldes, A. J., Garnero, P., Griesmacher, Andrea, McClung, Michael R., Morris, Howard A., Silverman, S., Trenti, Tommaso, Wahl, D. A., Cooper, Cyrus and Kanis, John A.. (2011). Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporosis International. 22(2), pp. 391 - 420. https://doi.org/10.1007/s00198-010-1501-1
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women
Cummings, Steven R., McClung, Michael R., Reginster, Jean-Yves, Cox, David, Mitlak, Bruce, Stock, John, Amewou-Atisso, Messan, Powles, Trevor, Miller, Paul, Zanchetta, Jose Ruben and Christiansen, Claus. (2011). Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women. Journal of Bone and Mineral Research. 26(2), pp. 397 - 404. https://doi.org/10.1002/jbmr.191
Secular trends in the incidence of hip and other osteoporotic fractures
Cooper, Cyrus, Cole, Z. A., Holroyd, C. R., Earl, S. C., Harvey, Nicholas C., Dennison, Elaine M., Melton, Lisa, Cummings, Steven R. and Kanis, John A.. (2011). Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporosis International. 22(5), pp. 1277 - 1288. https://doi.org/10.1007/s00198-011-1601-6
International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis
Vasikaran, Samuel, Cooper, Cyrus, Eastell, Richard, Griesmacher, Andrea, Morris, Howard A., Trenti, Tommaso and Kanis, John A.. (2011). International osteoporosis foundation and international federation of clinical chemistry and laboratory medicine position on bone marker standards in osteoporosis. Clinical Chemistry and Laboratory Medicine. 49(8), pp. 1271 - 1274. https://doi.org/10.1515/CCLM.2011.602
Validation of the IOF quality of life questionnaire for patients with wrist fracture
Lips, P., Jameson, Karen A., Bianchi, Maria L., Goemaere, Stefan, Boonen, Steven, Reeve, Jonathan, Stepan, Jan J., Johnell, O., van Schoor, Natasja M., Dennison, Elaine M., Kanis, John and Cooper, Cyrus. (2010). Validation of the IOF quality of life questionnaire for patients with wrist fracture. Osteoporosis International. 21(1), pp. 61 - 70. https://doi.org/10.1007/s00198-009-0946-6
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
Compston, Juliet E., Cooper, Alun, Cooper, Cyrus, Francis, Roger M., Kanis, John, Marsh, D., McCloskey, Eugene, Reid, David M., Selby, P. and Wilkins, M.. (2009). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 62(2), pp. 105 - 108. https://doi.org/10.1016/j.maturitas.2008.11.022
Case finding for the management of osteoporosis with FRAX® - Assessment and intervention thresholds for the UK
Kanis, John, McCloskey, Eugene, Johansson, Helena, Ström, O., Borgström, F., Oden, Anders, Compston, Juliet E., Cooper, Alun, Cooper, Cyrus, Francis, Roger M., Marsh, D., Reid, David M., Selby, P. and Wilkins, M.. (2008). Case finding for the management of osteoporosis with FRAX® - Assessment and intervention thresholds for the UK. Osteoporosis International. 19(10), pp. 1395 - 1408. https://doi.org/10.1007/s00198-008-0712-1
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
Kanis, John, Oden, Anders, Johnell, O., Johansson, Helena, Laet, C. De, Brown, Jacques P., Burckhardt, Peter, Cooper, Cyrus, Christiansen, Claus, Cummings, Steven R., Eisman, John A., Fujiwara, S., Glüer, C. C., Goltzman, David, Hans, Didier, Krieg, Marc Antoine, Lacroix, Andrea Z., McCloskey, Eugene, Mellström, Dan, ... Yoshimura, N.. (2007). The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporosis International. 18(8), pp. 1033 - 1046. https://doi.org/10.1007/s00198-007-0343-y
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks
van Staa, T. P., Kanis, John, Geusens, P., Boonen, Annelies, Leufkens, H. G. M. and Cooper, Cyrus. (2007). The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks. Value in Health. 10(5), pp. 348 - 357. https://doi.org/10.1111/j.1524-4733.2007.00188.x
A simple clinical score for estimating the long-term risk of fracture in post-menopausal women
van Staa, T. P., Geusens, P., Kanis, J. A., Leufkens, H. G. M., Gehlbach, S. and Cooper, C.. (2006). A simple clinical score for estimating the long-term risk of fracture in post-menopausal women. QJM: An International Journal of Medicine. 99(10), pp. 673-682. https://doi.org/10.1093/qjmed/hcl094